Type 2 diabetes, definitions combined, including avohilmo

T2D_INCLAVO

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions not E4_DM1	507042
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — E11 1 out of 7 registries used, show all original rules.	64276
4. Check minimum number of events None	64276
5. Include endpoints T2D_WIDE E4_DM2	89759
6. Filter based on genotype QC (FinnGen only)	89759

Control definitions (FinnGen only)

Control conditions: not E4_DM1

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	T2D_INCLAVO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!E4_DM1
SEX
INCLUDE	T2D_WIDE\|E4_DM2
PRE_CONDITIONS
CONDITIONS	!E4_DM1
OUTPAT_ICD	E11
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Type 2 diabetes, definitions combined, including avohilmo based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	89759	40948	48811
Unadjusted period prevalence (%)	18.07	13.96	21.52
Median age at first event (years)	60.83	60.15	61.41

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
17802: Matched controls
138709

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A10BJ01

ATC

exenatide; parenteral

+∞

323.0

363

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

+∞

323.0

10261

E66

ICD-10 Finland

Obesity

5.0

323.0

1590

2680

E66.00

ICD-10 Finland

Metabolic syndrome

12.8

323.0

2161

1476

G47.3

ICD-10 Finland

Sleep apnoea

3.5

323.0

5006

13915

160

Kela drug reimbursment

exenatide

+∞

323.0

850

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

114.4

323.0

430

R5140

NOMESCO Finland

Monitoring the use of the aid

3.4

323.0

2075

5172

C07AB07

ATC

bisoprolol; oral

2.7

323.0

6500

24009

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

216.8

323.0

1121

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

+∞

323.0

512

A10AE04

ATC

insulin glargine; parenteral

340.1

323.0

2164

C09AA05

ATC

ramipril; oral

4.0

323.0

2969

6656

A10BJ02

ATC

liraglutide; parenteral

136.2

323.0

1115

A10BK03

ATC

empagliflozin; oral

2064.6

323.0

3757

E66.8

ICD-10 Finland

Other obesity

6.3

323.0

2473

3448

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

14.3

323.0

6904

5892

SPAT1305

SPAT

Counselling and guidance related to physical exercise

3.8

323.0

1769

3897

A10BD20

ATC

metformin and empagliflozin; systemic

+∞

323.0

389

T82

ICPC

Obesity

6.6

323.0

1581

2033

162

Kela drug reimbursment

liraglutide

+∞

323.0

424

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

323.0

3036

A10BH02

ATC

vildagliptin; oral

2856.0

323.0

367

C10AA07

ATC

rosuvastatin; oral

4.6

323.0

4263

8949

A10AE05

ATC

insulin detemir; parenteral

328.4

323.0

886

215

Kela drug reimbursment

Diabetes, non-insulin-treated

6928.9

323.0

11948

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

714.9

323.0

360

SPAT1262

SPAT

Handing over of treatment supplies

20.4

323.0

5813

3214

C08CA01

ATC

amlodipine; oral

3.4

323.0

4679

13286

A10BA02

ATC

metformin; oral

936.7

323.0

15246

880

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

99.5

323.0

533

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

4.7

323.0

2708

5146

C03CA01

ATC

furosemide; systemic

3.9

323.0

2696

6051

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

2.9

323.0

2738

8197

C09CA01

ATC

losartan; oral

2.9

323.0

3474

10753

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

20.5

323.0

1233

502

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

323.0

2744

A10BX04

ATC

[U] exenatide; parenteral

+∞

323.0

376

205

Kela drug reimbursment

Chronic hypertension

5.5

323.0

3347

5577

A10BB12

ATC

glimepiride; oral

597.6

323.0

946

C10AA01

ATC

simvastatin; oral

5.9

323.0

5763

10412

C10AA05

ATC

atorvastatin; oral

5.1

323.0

5948

12413

XCK10

NOMESCO Finland

Photography of fundus of eye

7.0

323.0

1512

1816

A10BD07

ATC

metformin and sitagliptin; systemic

13407.1

323.0

1578

A10BK01

ATC

dapagliflozin; oral

609.0

323.0

2138

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

68.2

323.0

1276

157

E66.01

ICD-10 Finland

Obesity due to excess calories

6.4

323.0

3650

5348

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

3.2

323.0

2764

7545

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

+∞

323.0

2494

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

6.0

323.0

3689

5812

103

Kela drug reimbursment

Diabetes, insulin-treated

5966.4

323.0

12022

C10AX09

ATC

ezetimibe; oral

4.5

323.0

1298

2382

A10BX07

ATC

[U] liraglutide; parenteral

+∞

323.0

475

A10AE06

ATC

insulin degludec; parenteral

398.3

323.0

450

A10BG03

ATC

pioglitazone; oral

1010.3

323.0

626

SPAT1310

SPAT

Counselling related to known health issue

2.3

323.0

5547

22719

A10BJ06

ATC

semaglutide; parenteral

+∞

323.0

2057

E66.9

ICD-10 Finland

Obesity, unspecified

6.4

323.0

1217

1569

A10BH05

ATC

linagliptin; oral

3592.0

323.0

893

A10BJ05

ATC

dulaglutide; parenteral

+∞

323.0

364

A10BH01

ATC

sitagliptin; oral

2064.2

323.0

3593

E11

ICD-10 Finland

Type 2 diabetes mellitus

+∞

323.0

7836

C09AA02

ATC

enalapril; systemic

3.7

323.0

2296

5295

N05AH04

ATC

quetiapine; oral

2.4

323.0

3841

14533

T90

ICPC

Diabetes non-insulin dependent

268.8

323.0

10809

793

I10

ICD-10 Finland

Essential (primary) hypertension

4.8

323.0

9550

27120

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.9

323.0

2237

4913

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

+∞

323.0

364

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3613.9

323.0

460

SPAT1249

SPAT

Treatment-related counselling outside office

1.9

312.7

6668

33082

A10BD15

ATC

metformin and dapagliflozin; systemic

+∞

301.3

318

N05AX08

ATC

risperidone; systemic

3.6

299.4

1551

3602

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

6.8

296.2

825

983

SPAT1054

SPAT

Examination of peripheral nervous system

50.1

291.3

384

M04AA01

ATC

allopurinol; systemic

4.6

276.9

1075

1912

A10BX09

ATC

[U] dapagliflozin; oral

786.3

275.8

298

C08CA13

ATC

lercanidipine; oral

3.5

275.3

1463

3459

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.8

273.1

2034

6102

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.9

268.5

1878

5408

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

7.6

267.4

688

727

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

265.5

4713

21535

N05AX12

ATC

aripiprazole; systemic

3.7

263.8

1282

2812

N05AH02

ATC

clozapine; systemic

6.1

263.0

796

1060

T89

ICPC

Diabetes insulin dependent

72.1

261.9

327

N05AH03

ATC

olanzapine; systemic

3.2

258.5

1585

4166

N06AB04

ATC

citalopram; systemic

2.0

257.0

4158

18286

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

+∞

252.8

267

N05AA02

ATC

levomepromazine; systemic

4.4

250.8

1014

1875

EBA00

NOMESCO Finland

Extraction of tooth

1.8

249.2

5638

27968

N02BE01

ATC

paracetamol; systemic, rectal

1.9

246.4

14666

98303

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

4.3

238.6

990

1876

C09DA01

ATC

losartan and diuretics; oral

3.3

238.4

1378

3462

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.8

236.3

1143

2490

N06AX16

ATC

venlafaxine; oral

2.1

235.4

3270

13441

C03AA03

ATC

hydrochlorothiazide; oral

4.0

234.7

1050

2135

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

230.9

5425

27094

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

3.1

230.2

1446

3854

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

971.1

228.5

246

N05CD07

ATC

temazepam; oral

2.9

226.1

1544

4353

SPAT1263

SPAT

Sampling

1.7

225.9

6778

36483

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

15.5

225.3

404

207

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

33.3

223.4

319

A10BX01

ATC

guar gum; systemic

11.0

217.0

452

327

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.4

216.3

2204

7818

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.9

215.9

1527

4398

177

Kela drug reimbursment

Insulin glargine 300 U / ml

614.9

215.3

234

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

5.5

215.0

703

1028

A02BC02

ATC

pantoprazole; systemic

1.7

214.1

10414

63887

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.3

213.5

2377

8804

WX110

NOMESCO Finland

Local anesthesy

1.7

212.8

12568

81323

6488A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Abnormal glucose tolerance

5.9

210.4

652

892

R03AC02

ATC

salbutamol; inhalant

1.6

210.2

9554

57401

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.5

209.9

3082

38542

K86

ICPC

Hypertension uncomplicated

3.4

209.2

1143

2743

K85

ICPC

Elevated blood pressure

2.7

208.7

1671

5189

C03DA01

ATC

spironolactone; oral

3.4

207.0

1145

2773

N02AX02

ATC

tramadol; systemic, rectal

1.7

202.5

6387

34562

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.4

201.3

673

1010

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.8

194.0

1457

4345

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.3

190.8

2109

7750

A46

ICD-10 Finland

Erysipelas

2.5

188.6

1633

5289

C07AB02

ATC

metoprolol; systemic

2.3

187.2

2009

7276

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

7.2

187.0

496

547

C09BA02

ATC

enalapril and diuretics; systemic

4.5

185.4

736

1330

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

184.2

2661

10994

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.3

183.7

1042

2565

N05BA04

ATC

oxazepam; oral

1.8

182.9

4239

20758

L17

ICPC

Foot/toe symptom/complaint

1.9

181.9

3532

16299

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

179.5

4168

20401

N05AB03

ATC

perphenazine; systemic, rectal

3.8

179.4

860

1850

H03AA01

ATC

levothyroxine sodium; systemic

1.8

178.8

3959

19079

I50.9

ICD-10 Finland

Heart failure, unspecified

5.4

178.4

595

889

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.3

175.9

1929

7045

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

175.2

3880

18682

A10BD03

ATC

metformin and rosiglitazone; systemic

1412.7

174.7

187

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

172.1

10212

64104

J01DB01

ATC

cefalexin; oral

1.7

171.5

14280

97750

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

7.3

170.2

449

491

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

169.7

2824

12292

N06AB03

ATC

fluoxetine; oral

2.0

169.7

2403

9817

I25.1

ICD-10 Finland

Atherosclerotic heart disease

3.2

167.1

966

2409

CK2S4

SPAT

360.8

166.6

184

SPAT1260

SPAT

Consultation of another employee

2.0

165.9

2493

10424

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

165.2

3537

16795

SPAT1301

SPAT

No procedures

1.7

164.9

4229

21245

P72

ICPC

Schizophrenia

5.1

164.0

567

883

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.6

162.7

618

1066

N05AF03

ATC

chlorprothixene; systemic

4.0

162.3

729

1479

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

161.2

3748

18253

WX722

NOMESCO Finland

PEEP

4.2

160.8

681

1309

WX290

NOMESCO Finland

Other blockade of nerve

1.5

160.7

9012

55390

A10BX02

ATC

repaglinide; oral

460.6

160.7

176

N05BA01

ATC

diazepam; systemic, rectal

2.1

160.2

2141

8523

B01AB05

ATC

enoxaparin; parenteral

1.7

160.0

3916

19370

A10BG02

ATC

rosiglitazone; oral

679.7

159.6

173

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

11.5

158.2

322

222

J01FF01

ATC

clindamycin; systemic

1.7

157.8

4377

22452

A10BD08

ATC

metformin and vildagliptin; systemic

1367.6

156.7

168

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

19.9

155.8

255

101

CL2S4

SPAT

199.2

155.7

177

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

24.0

155.0

240

C09DA06

ATC

candesartan and diuretics; oral

3.1

154.7

967

2548

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.3

153.1

1593

5651

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

151.8

5313

28978

N05CF01

ATC

zopiclone; oral

1.7

151.5

4510

23548

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.3

151.1

510

772

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.3

151.0

1538

5398

SPAT1254

SPAT

Administration of medicine

2.2

150.4

1702

6282

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

149.7

7226

42616

C09CA06

ATC

candesartan; oral

1.8

149.2

3264

15537

C09CA03

ATC

valsartan; oral

3.0

149.0

989

2711

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

22.2

149.0

236

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

3.7

148.2

713

1535

K05.31

ICD-10 Finland

Periodontitis pronounced

2.4

146.1

1352

4514

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

146.0

2732

12332

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

145.3

4745

25348

H02AB06

ATC

prednisolone; systemic

1.5

144.8

7211

42724

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

142.8

6516

37791

T45

ICPC

Metabolic, Observ/health educat/advice/diet

12.8

142.4

276

171

C10AA03

ATC

pravastatin; oral

4.8

142.4

525

877

OAB50

SPAT

14.7

141.2

258

139

N06AB06

ATC

sertraline; oral

2.0

140.8

2246

9557

358

Kela drug reimbursment

liraglutide

+∞

140.0

148

K02.1

ICD-10 Finland

Caries of dentine

1.5

139.9

10538

68198

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

138.5

1234

4033

N03AX16

ATC

pregabalin; oral

1.7

138.5

3572

17829

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.5

137.4

1198

3869

A10BK02

ATC

canagliflozin; oral

+∞

137.1

145

S18

ICPC

Laceration/cut

1.6

137.0

5303

29492

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

136.0

5372

30009

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

34.3

135.8

192

M10.9

ICD-10 Finland

Gout, unspecified

5.0

135.3

481

772

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

135.0

2303

10034

R06.0

ICD-10 Finland

Dyspnoea

1.8

134.9

3020

14425

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.3

132.4

1338

4664

N97.0

ICD-10 Finland

Female infertility associated with anovulation

3.8

132.4

630

1343

N03AG01

ATC

valproic acid; systemic, rectal

2.4

132.0

1248

4206

SPAT1252

SPAT

Overall medication plan or its review

3.2

131.1

768

1928

N06AX21

ATC

duloxetine; oral

1.9

130.6

2125

9091

C02AC05

ATC

moxonidine; oral

5.6

130.4

419

598

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

15.6

130.3

232

117

SPAT1281

SPAT

Other administrative function

2.4

130.2

1195

3964

N06AX11

ATC

mirtazapine; oral

1.6

129.9

5250

29415

C10AB05

ATC

fenofibrate; oral

9.2

129.8

296

255

C10AA04

ATC

fluvastatin; oral

4.5

129.2

502

885

S10

ICPC

Boil/carbuncle

2.9

128.7

895

2526

SPAT1139

SPAT

Nutrition survey

4.1

128.6

550

1065

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

10.7

128.5

270

199

R73

ICD-10 Finland

Elevated blood glucose level

4.8

128.1

466

767

SPAT1312

SPAT

General health counselling

1.6

127.7

4644

25332

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

+∞

126.7

134

N05BA06

ATC

lorazepam; systemic, sublingual

3.1

125.7

761

1955

A10BB01

ATC

glibenclamide; oral

532.9

124.7

136

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

11.8

124.0

249

167

N06AX12

ATC

bupropion; oral

2.1

123.9

1519

5788

C09DA03

ATC

valsartan and diuretics; oral

4.0

123.7

549

1100

N05AN01

ATC

lithium; oral

3.5

122.6

630

1430

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

122.4

8874

56207

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

121.5

9369

60050

N04AA02

ATC

biperiden; systemic

4.5

121.4

470

826

K08.3

ICD-10 Finland

Retained dental root

2.6

121.2

981

3033

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.9

120.2

2138

9425

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

119.7

3171

15854

SGA01

NOMESCO Finland

Tooth opening as first aid

1.7

119.0

3353

17054

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.8

118.6

2267

10241

J01AA02

ATC

doxycycline; systemic

1.5

118.5

13229

91214

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.9

118.4

1995

8622

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

116.1

1335

4936

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

115.2

7529

46480

C07BB07

ATC

bisoprolol and thiazides; systemic

4.1

115.1

492

952

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

115.1

1006

3245

L15

ICPC

Knee symptom/complaint

1.7

114.8

2728

13195

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

485.4

113.4

124

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.5

113.3

1273

17595

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

113.2

12852

88346

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

113.1

1921

8316

N06AB10

ATC

escitalopram; oral

1.6

113.0

3994

21514

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.3

112.7

1218

4374

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

111.6

1361

5163

N06AA09

ATC

amitriptyline; systemic

2.1

111.5

1423

5506

A06AD11

ATC

lactulose; oral

2.2

111.4

1323

4961

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.9

111.4

739

2019

M79.6

ICD-10 Finland

Pain in limb

1.5

110.7

5458

31709

A02BC01

ATC

omeprazole; systemic

1.6

110.6

3669

19435

L28

ICPC

Limited function/disability (L)

2.1

109.8

1451

5696

SPAT1100

SPAT

Long-term monitoring of blood pressure

3.5

109.2

561

1273

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

6.4

109.2

312

383

N03AX09

ATC

lamotrigine; oral

2.3

108.7

1117

3912

T31

ICPC

Metabolic, Medical examin/health eval partial

17.5

108.5

185

SPAT1240

SPAT

Therapeutic discussion

1.8

107.6

2127

9691

C09CA07

ATC

telmisartan; oral

2.6

106.2

846

2586

B01AC04

ATC

clopidogrel; oral

2.8

106.2

780

2271

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.9

106.0

703

1918

P76

ICPC

Depressive disorder

2.1

105.6

1351

5227

E66.0

ICD-10 Finland

Obesity due to excess calories

9.8

104.4

229

184

WX780

NOMESCO Finland

Remote monitoring CPAP

2.8

104.3

741

2115

EBA30

NOMESCO Finland

Excision of root of tooth

2.8

104.3

732

2074

A28

ICPC

Limited function/disability NOS

2.5

104.1

926

3012

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

103.9

1302

4993

C01DA14

ATC

isosorbide mononitrate; oral

4.1

103.6

444

861

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.8

102.9

2201

10275

J01MA12

ATC

levofloxacin; systemic

1.8

102.7

2168

10080

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

102.3

1993

9027

J01FA06

ATC

roxithromycin; oral

1.4

102.2

6644

40653

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.6

102.2

3108

16052

C08CA02

ATC

felodipine; oral

3.1

102.0

609

1548

N05AD01

ATC

haloperidol; systemic

3.8

101.7

477

1003

M54.5

ICD-10 Finland

Low back pain

1.5

101.0

5538

32735

R05

ICPC

Cough

1.6

100.4

3240

16980

T83

ICPC

Overweight

3.9

100.4

460

948

N05AC02

ATC

thioridazine; oral

4.2

99.8

419

797

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

99.3

5828

34895

L03

ICPC

Low back symptom/complaint

1.6

99.1

3620

19554

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.7

98.7

476

1025

N03AX12

ATC

gabapentin; oral

1.7

98.5

2277

10875

T90

ICD-10 Finland

Sequelae of injuries of head

149.0

98.5

114

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

98.2

1360

5430

N05AA01

ATC

chlorpromazine; systemic, rectal

4.8

98.0

355

582

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

97.8

1696

7374

SPAT1097

SPAT

Recording of ECG

2.0

97.7

1460

6010

WX723

NOMESCO Finland

CPAP therapy

2.9

97.6

668

1860

SPAT1234

SPAT

Support of social functional capacity

3.3

97.4

539

1295

H3601, E113

ICD-10 Finland

+∞

97.3

103

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

97.1

1735

7620

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

96.7

811

2553

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

96.4

10586

70971

R03BB04

ATC

tiotropium bromide; inhalant

2.4

95.6

890

2962

R02

ICPC

Shortness of breath/dyspnoea

2.0

95.6

1428

5876

XG466

NOMESCO Finland

Sleep oxymetry

3.5

95.4

500

1152

S97

ICPC

Chronic ulcer skin

3.7

95.1

454

969

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.2

95.1

1040

3748

C09DA07

ATC

telmisartan and diuretics; oral

3.3

95.0

522

1248

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

+∞

94.5

100

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

94.0

3253

17312

R60.0

ICD-10 Finland

Localized oedema

2.1

93.9

1160

4415

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4.6

93.7

359

624

W85

ICPC

Gestational diabetes

2.5

92.9

810

2602

P99

ICPC

Psychological disorders other

2.9

92.5

634

1766

R06.5

ICD-10 Finland

Mouth breathing

2.0

91.8

1357

5555

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

91.7

2743

14055

F61.0

ICD-10 Finland

Mixed personality disorders

3.4

91.4

494

1166

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.1

90.5

550

1415

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.3

90.5

950

3356

A10AB06

ATC

insulin glulisine; parenteral

751.3

88.8

AN1

Coronary angiography

3.1

88.7

530

1346

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

88.2

1217

4844

P06

ICPC

Sleep disturbance

1.8

87.9

1637

7281

N06AX03

ATC

mianserin; oral

2.6

87.3

720

2241

K04.0

ICD-10 Finland

Pulpitis

1.7

86.8

2070

9947

P29

ICPC

Psychological sympt/compl other

2.1

86.4

1135

4427

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

86.3

5942

36403

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.4

86.2

818

2747

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.8

85.8

622

1795

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

84.7

8710

57128

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

84.4

2567

13185

207

Kela drug reimbursment

Chronic arrhythmias

3.0

84.1

532

1406

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.9

83.7

1438

6215

C07AG02

ATC

carvedilol; oral

3.6

83.4

419

934

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

83.3

1580

7063

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

83.2

1543

6847

H3600, E113

ICD-10 Finland

+∞

83.2

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.9

82.4

1290

5389

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.6

82.1

408

901

M02AA07

ATC

piroxicam; topical

1.4

81.9

4788

28385

N05BA12

ATC

alprazolam; oral

1.8

81.8

1632

7416

I50.0

ICD-10 Finland

Congestive heart failure

6.4

81.7

234

289

SPAT1153

SPAT

Removal of sutures

1.5

81.4

3655

20541

RD210

NOMESCO Finland

4.1

81.4

342

652

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

1.5

81.3

2967

15920

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

81.1

1636

7461

M10

ICD-10 Finland

Gout

4.2

81.0

334

625

R05FB02

ATC

cough suppressants and expectorants

1.4

80.6

5334

32338

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

85.3

80.5

S20

ICPC

Corn/callosity

6.8

80.2

219

253

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

80.2

1838

8717

R4190

NOMESCO Finland

Nutritional therapy

2.8

80.2

574

1644

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.4

79.8

432

1021

A02BC03

ATC

lansoprazole; oral

1.5

79.7

3967

22762

J01DA01

ATC

[U] cefalexin; systemic

1.4

79.1

10517

71532

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

0.5

79.0

978

13269

M01AB05

ATC

diclofenac; systemic, rectal

1.4

78.9

11350

78168

N05BE01

ATC

buspirone; oral

2.9

78.9

538

1494

N06AA12

ATC

doxepin; systemic

2.5

78.5

686

2205

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.7

78.2

2652

28723

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

22.8

78.1

122

T93

ICPC

Lipid disorder

2.8

78.1

561

1610

N07BA03

ATC

varenicline; oral

2.0

77.8

1048

4127

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.8

77.7

1516

6833

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

77.7

898

3312

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

4.5

77.7

297

516

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

77.0

2461

12768

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

76.9

948

3595

P03

ICPC

Feeling depressed

1.7

76.8

1689

7907

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

76.5

1060

4222

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

76.4

3517

19834

N07BB01

ATC

disulfiram; oral

2.2

76.2

820

2925

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

76.0

5329

32557

T29

ICPC

Endocr/metab/nutr sympt/compl other

4.8

76.0

278

461

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

4.5

75.7

290

505

P01AB01

ATC

metronidazole; oral, rectal

1.4

75.4

6739

42882

C09AA03

ATC

lisinopril; oral

3.5

75.1

382

860

188

Kela drug reimbursment

Psychosis requiring demanding treatment

4.2

75.1

311

585

C09AA04

ATC

perindopril; oral

3.0

74.8

465

1215

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

74.6

856

3145

SPAT1229

SPAT

Assessment of need for aid

2.4

73.8

688

2288

L08

ICPC

Shoulder symptom/complaint

1.6

73.6

2366

12283

N06AB05

ATC

paroxetine; oral

1.9

73.3

1156

4834

G03DB01

ATC

dydrogesterone; oral

1.5

72.9

2974

16319

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

72.5

1383

6179

UJF32

NOMESCO Finland

Coloscopy

1.5

72.4

2893

15797

SPAT1377

SPAT

Polysomnography

2.6

72.1

578

1770

F20

ICD-10 Finland

Schizophrenia

6.6

72.0

200

237

N02AA05

ATC

oxycodone; systemic

1.9

71.5

1187

5058

J20

ICD-10 Finland

Acute bronchitis

1.8

71.1

1370

6142

WZA90

NOMESCO Finland

Other doctors statement

1.5

70.9

3437

19545

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

70.7

1672

7987

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

58.8

70.5

H36.00

ICD-10 Finland

Diabetic background retinopathy

158.5

70.4

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

4.2

70.3

292

551

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

70.3

873

3320

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

2.8

70.2

480

1336

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

5.3

69.8

231

343

N05AF05

ATC

zuclopenthixol; systemic

4.9

69.6

247

397

S29

ICPC

Skin symptom/complaint other

1.6

69.1

1884

9361

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

5.1

68.9

238

371

A08AB01

ATC

orlistat; oral

14.6

68.9

125

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

68.6

2975

16513

SPAT1216

SPAT

Assessment of functional ability

1.9

68.6

1201

5209

OAB42

SPAT

2.3

68.5

692

2394

A02BA02

ATC

ranitidine; systemic

1.6

68.3

2271

11866

A02BC05

ATC

esomeprazole; systemic

1.4

68.3

5963

37618

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.1

68.2

884

3420

E14.8

ICD-10 Finland

Unspecified diabetes mellitus, with unspecified complications

44.5

68.2

6480A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus

10.8

68.1

141

102

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

67.8

2965

16480

R96

ICPC

Asthma

1.9

67.6

1130

4822

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.9

67.5

437

1174

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

67.2

1243

5494

AA1AD

NOMESCO Finland

CT of head and brain

1.6

67.0

2243

11737

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

66.6

1298

5835

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.8

66.4

456

1272

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

5.7

66.2

205

281

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

66.1

3665

21353

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

3.5

65.9

335

754

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

65.3

3802

22341

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

65.2

2498

13482

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

63.8

2631

14424

201

Kela drug reimbursment

Chronic cardiac insufficiency

3.8

63.6

292

604

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

5.0

63.5

221

348

ACC51

NOMESCO Finland

Release of median nerve

1.8

63.4

1158

5094

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.9

62.9

1072

4603

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.9

62.9

419

1146

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.8

62.8

443

1256

M01AX17

ATC

nimesulide; oral

1.5

62.7

2902

16291

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.6

62.6

1985

10233

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.6

62.6

509

1571

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

+∞

62.4

E14

ICD-10 Finland

Unspecified diabetes mellitus

41.1

62.1

K04.1

ICD-10 Finland

Necrosis of pulp

1.6

62.0

1799

9068

B01AA03

ATC

warfarin; systemic

1.9

61.5

959

3989

A10BD05

ATC

metformin and pioglitazone; systemic

523.0

61.5

N05AE04

ATC

ziprasidone; systemic

4.8

61.2

219

356

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.5

61.0

539

1741

D11

ICPC

Diarrhoea

1.6

61.0

1873

9577

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

60.9

3188

18325

R11

ICD-10 Finland

Nausea and vomiting

1.9

60.8

972

4081

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.8

60.5

414

1152

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

60.3

935

3882

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

60.2

3953

23673

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

5.4

60.2

194

280

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.0

60.1

380

1004

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.5

59.9

502

1577

L73.2

ICD-10 Finland

Hidradenitis suppurativa

3.8

59.9

272

558

K85

ICD-10 Finland

Acute pancreatitis

4.7

59.8

219

365

SPAT1211

SPAT

Application of soft bandage

1.9

59.8

967

4075

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

4.9

59.6

212

342

A01

ICPC

Pain general/multiple sites

1.9

59.6

943

3943

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

59.6

1416

6756

OAB72

NOMESCO Finland

Weight control and weight loss guidance

5.0

59.4

205

320

L16

ICPC

Ankle symptom/complaint

1.7

59.4

1338

6283

L60.0

ICD-10 Finland

Ingrowing nail

2.3

59.3

578

1965

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.2

59.2

672

2454

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.4

59.1

524

1696

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

59.0

798

3142

T99

ICPC

Endocr/metab/nutrit disease other

4.2

59.0

243

456

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

58.9

840

3375

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.1

58.6

360

932

A10BD11

ATC

metformin and linagliptin; systemic

+∞

58.6

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

6.7

58.3

160

187

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

58.3

7229

47702

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.1

58.3

353

906

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

0.6

58.2

953

12108

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

58.1

3262

18978

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.9

57.7

257

518

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

57.6

1355

6446

E78

ICD-10 Finland

Disorders of lipoprotein metabolism and other lipidaemias

3.3

57.3

309

730

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

57.3

670

2479

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

5.8

57.2

176

240

K04.08

ICD-10 Finland

Other specified pulpit

1.7

57.2

1297

6102

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.0

57.1

350

907

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.0

56.8

758

2967

D07AC01

ATC

betamethasone; topical

1.3

56.7

4753

29577

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.2

56.6

598

2113

XF402

NOMESCO Finland

ECG with work load test

1.9

56.5

902

3784

MAX99

NOMESCO Finland

Assistance to normal delivery

0.5

56.4

656

9096

B02AA02

ATC

tranexamic acid; systemic

1.4

56.3

3020

17408

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

56.1

1771

9106

S22

ICPC

Nail symptom/complaint

2.2

55.9

638

2337

N06AX05

ATC

trazodone; oral

2.5

55.8

476

1510

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

5.0

55.8

194

306

C03BA11

ATC

indapamide; oral

4.3

55.6

223

408

M48.0

ICD-10 Finland

Spinal stenosis

1.9

55.5

830

3396

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

4.7

55.5

203

338

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.9

55.5

863

3584

F22.0

ICD-10 Finland

Delusional disorder

3.7

55.1

265

571

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

54.9

693

2650

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

4.2

54.7

224

418

SPAT1058

SPAT

PEF monitoring instruction

1.9

54.7

901

3820

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

54.7

1357

6549

Z72.0

ICD-10 Finland

Tobacco use

2.7

54.7

415

1233

H01

ICPC

Ear pain/earache

1.6

54.6

1577

7924

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.6

54.4

1703

8737

R06AE07

ATC

cetirizine; oral

1.3

54.3

7416

49408

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.6

54.2

415

1238

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.5

54.1

453

1421

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

53.9

894

3801

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

53.4

840

3502

J01FA09

ATC

clarithromycin; systemic

1.3

53.2

5293

33724

R03BA05

ATC

fluticasone; inhalant

1.4

53.2

2750

15725

R42

ICD-10 Finland

Dizziness and giddiness

1.5

52.9

2256

12410

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

52.7

11901

84522

E10

ICD-10 Finland

Type 1 diabetes mellitus

72.6

52.6

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.6

52.5

421

1290

I42.0

ICD-10 Finland

Dilated cardiomyopathy

3.9

52.3

235

478

N03AE01

ATC

clonazepam; systemic

1.9

52.3

815

3385

A99

ICPC

Disease/condition unspecnature/site

1.9

52.2

876

3735

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

52.2

2252

12412

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.8

52.0

363

1023

J01MA02

ATC

ciprofloxacin; systemic

1.3

51.9

4743

29817

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

51.7

860

3658

R03BA01

ATC

beclometasone; inhalant

1.5

51.3

2000

10786

F43

ICPC

Eye, Other diagnostic procedure

4.3

51.1

204

372

SPAT1081

SPAT

Cardiorespiratory global assessment

2.5

51.1

431

1359

P17

ICPC

Tobacco abuse

3.5

51.0

256

572

A91

ICPC

Abnormal result investigation NOS

2.4

50.9

453

1469

M03BX02

ATC

tizanidine; oral

1.3

50.8

11154

78692

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.1

50.6

306

786

WZC30

SPAT

3.5

50.6

256

576

D05AX52

ATC

calcipotriol, combinations; topical

2.0

50.6

750

3057

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

50.6

1176

5568

F34.1

ICD-10 Finland

Dysthymia

2.1

50.5

635

2426

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.6

50.5

245

533

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

5.0

50.5

173

269

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.7

50.4

384

1142

I50.1

ICD-10 Finland

Left ventricular failure

4.1

50.2

211

404

L90

ICPC

Osteoarthrosis of knee

2.3

50.1

509

1766

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

49.9

5787

37583

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

49.6

553

2004

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.5

49.6

255

581

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

49.5

4606

28994

B03BA03

ATC

hydroxocobalamin; parenteral

2.4

49.5

447

1461

H3603, E113

ICD-10 Finland

+∞

49.1

T66

ICPC

Metabolic, Referral to non-MD provider

+∞

49.1

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

49.0

506

1767

K07

ICPC

Swollen ankles/oedema

3.2

49.0

282

698

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

4.4

48.9

191

341

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

48.9

4275

26652

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

3.6

48.8

237

516

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.4

48.7

451

1495

T48

ICPC

Metabolic, Clarification/discussion RFE/demand

18.1

48.6

Z37.0

ICD-10 Finland

Single live birth

0.6

48.6

864

10789

B01AC24

ATC

ticagrelor; oral

3.5

48.5

244

547

O24.9

ICD-10 Finland

Diabetes mellitus in pregnancy, unspecified

2.6

48.5

382

1159

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

48.4

570

2116

SPAT1255

SPAT

Intravenous administration of medicine

2.0

48.4

701

2832

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

4.0

48.3

211

419

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

48.1

515

1833

T69

ICPC

Metabolic, Other reason for encounter NEC

36.9

47.9

C09DB01

ATC

valsartan and amlodipine; oral

3.0

47.8

301

795

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.9

47.8

780

3293

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.1

47.8

554

2044

M01AE02

ATC

naproxen; oral, rectal

1.3

47.7

9297

64356

N05BA02

ATC

chlordiazepoxide; systemic

2.9

47.6

309

833

H36.01

ICD-10 Finland

Diabetic maculopathy

143.3

47.6

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.1

47.6

289

745

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.8

47.6

217

448

SPAT1059

SPAT

Spirometry at the office

2.1

47.5

576

2165

R03AC03

ATC

terbutaline; inhalant

1.5

47.4

2119

11749

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.4

47.3

437

1447

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

47.2

4764

30294

M10.0

ICD-10 Finland

Idiopathic gout

4.3

47.2

187

339

A12BA01

ATC

potassium chloride; oral

4.7

47.2

173

290

M01AX05

ATC

glucosamine; oral

1.6

47.0

1307

6496

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

4.2

47.0

191

355

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

46.9

1417

7193

H13

ICPC

Plugged feeling ear

1.6

46.6

1475

7572

R03BA02

ATC

budesonide; inhalant

1.4

46.5

2577

14885

C09BA03

ATC

lisinopril and diuretics; oral

5.0

46.4

161

254

S76

ICPC

Skin infection other

2.1

46.2

545

2025

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

46.2

567

2141

L68.0

ICD-10 Finland

Hirsutism

4.3

46.1

184

336

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

3.8

45.9

210

435

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.4

45.8

429

1429

SPAT1325

SPAT

Vaccination

1.4

45.8

3205

19266

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

4.0

45.8

195

379

N05AB01

ATC

dixyrazine; systemic

4.3

45.7

182

332

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

4.3

45.5

183

337

H25.1

ICD-10 Finland

Senile nuclear cataract

2.1

45.5

582

2240

F21

ICD-10 Finland

Schizotypal disorder

4.5

45.3

174

306

A08

ICPC

Swelling

2.5

45.1

377

1182

SPAT1283

SPAT

Restricted health certificate

1.3

45.1

3758

23210

SPAT1104

SPAT

Monitoring of emergency patient

1.9

45.0

681

2797

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.1

44.9

526

1949

A29

ICPC

General symptom/complaint other

1.6

44.8

1137

5509

M02AA10

ATC

ketoprofen; topical

1.5

44.8

1969

10868

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

9.1

44.8

101

A09AA02

ATC

multienzymes (lipase, protease etc.)

4.2

44.6

184

347

U04

ICPC

Incontinence urine

2.5

44.4

364

1131

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

+∞

44.4

D07XC01

ATC

betamethasone, combinations; topical

1.6

44.3

1447

7481

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

44.3

701

2928

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

44.2

1566

8250

N06AG02

ATC

moclobemide; oral

2.0

44.1

578

2244

N05CF02

ATC

zolpidem; oral

1.4

44.0

2795

16519

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

43.8

11145

79232

A10BB07

ATC

glipizide; oral

373.7

43.7

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

4.6

43.7

162

275

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

43.7

2316

13255

C09BA04

ATC

perindopril and diuretics; systemic

4.3

43.7

173

314

E11.09

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - With coma

+∞

43.4

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

1.9

43.4

651

2666

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

43.3

465

1657

M01AH05

ATC

etoricoxib; oral

1.2

43.2

9901

69465

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.5

43.2

1696

9140

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.5

43.1

218

491

F31

ICD-10 Finland

Bipolar affective disorder

3.0

42.9

261

674

J01MA14

ATC

moxifloxacin; systemic

1.7

42.8

1062

5116

J45

ICD-10 Finland

Asthma

1.6

42.8

1368

7034

SPAT1360

SPAT

Extensive global examination

1.8

42.8

758

3293

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

42.7

965

4525

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.6

42.6

326

974

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.6

42.5

342

1050

S21

ICPC

Skin texture symptom/complaint

1.6

42.4

1241

6244

WX002

NOMESCO Finland

Sedation and analgesia

1.4

42.4

2089

11788

T60

ICPC

Metabolic, Result test/procedure

7.3

42.4

109

117

N05AF01

ATC

flupentixol; systemic

3.1

42.3

249

629

C01AA05

ATC

digoxin; systemic

3.8

42.2

193

400

SPAT1243

SPAT

Psychiatric/psychological examination

2.1

42.2

508

1904

QBJ30

NOMESCO Finland

Correction of abdominal apron

3.5

42.2

216

492

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

7.2

42.1

109

118

WZC30

NOMESCO Finland

Teaching

1.5

41.7

1454

7628

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.8

41.7

287

805

M01AC06

ATC

meloxicam; systemic, rectal

1.3

41.6

5259

34324

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

+∞

41.6

T62

ICPC

Metabolic, Administrative procedure

37.1

41.5

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

41.5

1593

8540

SPAT1285

SPAT

Provision of consultation response

2.0

41.5

564

2223

XCK10

SPAT

183.6

41.4

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

41.3

2172

12400

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.4

41.3

214

492

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.4

41.2

362

1168

Y6099

ICD-8 Finland

Prenatal care and observation

2.0

41.2

532

2055

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

41.1

808

3630

K22

ICPC

Risk factor cardiovascular disease

2.3

41.0

397

1346

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.2

40.9

234

580

F32

ICD-10 Finland

Depressive episode

1.7

40.8

920

4311

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

4.9

40.7

142

226

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

40.7

1290

6616

SPAT1284

SPAT

Extensive health certificate

2.3

40.7

423

1484

B01AF02

ATC

apixaban; oral

2.3

40.5

391

1325

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

4.2

40.4

164

305

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

40.4

398

1360

SPAT1053

SPAT

Memory test

2.5

40.2

331

1031

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

40.2

775

3462

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

40.1

1392

7295

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.7

39.9

941

4468

P20

ICPC

Memory disturbance

2.5

39.8

341

1085

A10BH03

ATC

saxagliptin; oral

+∞

39.7

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.1

39.6

464

1719

T28

ICPC

Limited function/disability (T)

4.7

39.5

145

244

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

39.5

2117

12121

M79.7

ICD-10 Finland

Fibromyalgia

1.9

39.4

628

2628

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

3.4

39.4

203

465

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

5.9

39.2

117

155

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.9

39.2

260

713

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.7

39.0

282

814

D01AC02

ATC

miconazole; topical

1.7

39.0

813

3722

I20.09

ICD-10 Finland

Unstable angina

3.0

38.9

245

649

F20.10

ICD-10 Finland

Raise schizophrenia continuously

5.9

38.8

116

154

A08AA10

ATC

sibutramine; oral

8.6

38.8

K04.09

ICD-10 Finland

Pulpit UNS

1.8

38.7

758

3404

N05AL01

ATC

sulpiride; systemic

3.2

38.6

220

544

TK800

NOMESCO Finland

Hemodialysis

3.4

38.5

197

449

K02.2

ICD-10 Finland

Caries of cementum

2.2

38.5

423

1524

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

3.3

38.4

210

504

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

38.4

1536

8301

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.4

38.2

349

1150

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

5.4

38.2

123

179

A08AA02

ATC

fenfluramine; oral (centrally acting antiobesity products)

4.8

38.2

136

222

B81

ICPC

Anaemia vit B12/folate deficiency

2.7

38.2

273

783

J01CA04

ATC

amoxicillin; systemic

1.3

38.2

13699

100413

F20.0

ICD-10 Finland

Paranoid schizophrenia

4.1

38.1

157

297

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.9

37.9

251

686

R95

ICPC

Chron obstructive pulmonary disease

4.3

37.9

150

273

C07FB02

ATC

metoprolol and felodipine; systemic

4.1

37.9

156

295

S06

ICPC

Rash localized

1.9

37.8

554

2251

E13

ICD-10 Finland

Other specified diabetes mellitus

39.8

37.7

R50.9

ICD-10 Finland

Fever, unspecified

1.5

37.6

1617

8868

A41.9

ICD-10 Finland

Sepsis, unspecified

2.8

37.6

263

746

SPAT1307

SPAT

Psychosocial counselling and guidance

1.6

37.5

981

4791

SPAT1101

SPAT

Orthostatic test

3.1

37.4

218

547

I25.2

ICD-10 Finland

Old myocardial infarction

3.6

37.4

180

391

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

1.8

37.3

735

3304

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.5

37.3

190

432

SPAT1094

SPAT

Continuous Positive Airway Pressure

3.8

37.3

167

341

T92

ICPC

Gout

5.7

37.3

114

156

T07

ICPC

Weight gain

3.2

37.2

207

503

P28

ICPC

Limited function/disability (P)

3.9

37.1

162

323

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.7

37.0

266

765

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

4.3

36.7

146

267

UKC02

NOMESCO Finland

Cystoscopy

1.6

36.7

1052

5261

H02AB04

ATC

methylprednisolone; systemic

1.4

36.7

1880

10667

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.8

36.5

2459

24336

Z71.8

ICD-10 Finland

Other specified counselling

1.3

36.4

3465

21709

L86

ICPC

Back syndrome with radiating pain

1.8

36.4

689

3058

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

36.3

433

1617

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.6

36.3

173

373

B01AB10

ATC

tinzaparin; parenteral

1.8

36.2

711

3195

R03DC03

ATC

montelukast; oral

1.3

36.1

2556

15322

SPAT1251

SPAT

Organisation of medication

2.4

36.1

332

1098

H02AB07

ATC

prednisone; oral

1.4

36.1

1730

9692

J46

ICD-10 Finland

Status asthmaticus

2.2

36.0

376

1324

M25.5

ICD-10 Finland

Pain in joint

1.3

35.8

4431

28726

O48

ICD-10 Finland

Prolonged pregnancy

0.4

35.7

157

2990

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.8

35.7

251

713

E78.11

ICD-10 Finland

Other hypertriglyceridemia

7.3

35.7

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.9

35.6

548

2266

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

4.2

35.5

144

269

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.8

35.4

690

3093

T30

ICPC

Metabolic, Medical examin/health eval complete

27.1

35.3

E87.6

ICD-10 Finland

Hypokalaemia

2.5

35.3

290

902

K86.1

ICD-10 Finland

Other chronic pancreatitis

5.8

35.3

106

142

A03

ICPC

Fever

1.3

35.2

2519

15122

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.1

35.2

434

1644

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.9

35.2

591

2521

L01

ICPC

Neck symptom/complaint

1.4

35.1

1843

10501

Z08

ICPC

Social welfare problem

3.0

35.0

217

570

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

7.7

34.9

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

34.9

502

2025

P73

ICPC

Affective psychosis

4.5

34.8

131

227

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

34.7

1067

5425

H25.8

ICD-10 Finland

Other senile cataract

2.8

34.6

234

651

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

3.1

34.6

202

509

SPAT1359

SPAT

Use of symptom diary

2.6

34.5

276

847

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

34.5

489

1961

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

34.4

811

3845

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

2.8

34.4

239

675

K03.66

ICD-10 Finland

Tooth plaque

1.7

34.4

706

3214

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

34.4

396

1458

D07AD01

ATC

clobetasol; topical

1.4

34.3

1991

11543

SPAT1146

SPAT

Puncture of abscess or incision of skin

3.0

34.3

216

572

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

34.3

836

4005

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.6

34.1

263

789

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

3.2

34.1

189

459

P01

ICPC

Feeling anxious/nervous/tense

1.4

34.0

1695

9562

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.4

34.0

1527

8440

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

34.0

5098

33770

A10AA02

ATC

43.9

34.0

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

0.7

33.9

1654

17163

N05AD03

ATC

melperone; systemic

3.8

33.9

155

323

JKA20

NOMESCO Finland

Cholecystectomy

2.9

33.8

219

592

G02BA03

ATC

plastic IUD with progestogen

0.7

33.7

1924

19506

R53

ICD-10 Finland

Malaise and fatigue

1.3

33.7

2500

15088

-45

ICPC

Observ/health educat/advice/diet

2.1

33.6

405

1521

C07AA05

ATC

propranolol; systemic

1.3

33.6

3062

19041

5742A

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder without mention of cholecystitis[CHOLECYSTOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]

2.8

33.6

226

625

D07AC13

ATC

mometasone; topical

1.3

33.6

4051

26138

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

33.6

818

3917

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.2

33.5

192

478

R04

ICPC

Breathing problem other

2.1

33.5

399

1491

R03AC13

ATC

formoterol; inhalant

1.8

33.4

594

2584

I25

ICD-10 Finland

Chronic ischaemic heart disease

4.2

33.3

135

252

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.6

33.2

957

4791

SGB20

NOMESCO Finland

Filling of root of tooth with 2 root channels

1.6

33.1

1058

5428

C07AB03

ATC

atenolol; systemic

2.3

33.1

314

1055

E66.1

ICD-10 Finland

Drug-induced obesity

7.2

33.1

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

33.0

594

2594

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

32.9

1296

6971

D10BA01

ATC

isotretinoin; oral

0.6

32.9

533

6821

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

32.7

2244

13368

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.9

32.7

212

573

K05.3

ICD-10 Finland

Chronic periodontitis

1.9

32.5

538

2282

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

32.5

388

1452

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

5.0

32.5

112

177

8811

FHL

Cesarean section

1.5

32.5

1237

6605

E0000UV

ATC

1.2

32.5

5655

38040

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

32.3

503

2088

Z00.0

ICD-10 Finland

General medical examination

1.4

32.3

2079

12259

C07AG01

ATC

labetalol; systemic

2.3

32.3

304

1020

B01AB04

ATC

dalteparin; parenteral

2.0

32.2

459

1846

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

32.2

928

4644

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

7.9

32.2

C07AB12

ATC

nebivolol; oral

2.2

32.2

340

1205

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

32.2

594

2616

A10BX12

ATC

[U] empagliflozin; oral

+∞

32.1

R32

ICD-10 Finland

Unspecified urinary incontinence

2.6

32.1

255

782

N30.0

ICD-10 Finland

Acute cystitis

1.4

32.0

1559

8747

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3.0

32.0

200

529

N19

ICD-10 Finland

Unspecified kidney failure

3.7

32.0

147

308

P15

ICPC

Chronic alcohol abuse

2.1

31.9

395

1501

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

5.3

31.8

104

155

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

7.1

31.8

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

9.1

31.8

IGV01

NOMESCO Finland

Psychiatric network contact

3.7

31.7

150

322

AN4

Balloon angioplasty and drug eluding stent

4.4

31.6

121

214

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

3.8

31.6

142

292

S01

ICPC

Pain/tenderness of skin

2.0

31.6

443

1770

B01AF01

ATC

rivaroxaban; oral

1.7

31.5

693

3224

KGH10

NOMESCO Finland

Operation for phimosis

2.9

31.5

209

574

104

Kela drug reimbursment

Thyroid insufficiency

1.6

31.4

823

4018

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

31.4

8160

57122

ZXA00

NOMESCO Finland

Right side

1.3

31.4

2728

16833

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.6

31.4

241

725

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.4

31.3

289

959

WX892

NOMESCO Finland

Monitored bed care

1.8

31.3

624

2818

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

4.0

31.3

134

264

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

31.3

699

3266

C08CA10

ATC

nilvadipine; oral

4.3

31.2

123

224

G63.2

ICD-10 Finland

Diabetic polyneuropathy

+∞

31.2

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

31.1

386

1468

D75.1

ICD-10 Finland

Secondary polycythaemia

5.7

31.0

131

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

7.0

31.0

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.0

31.0

401

1553

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

31.0

2903

18098

R01AD09

ATC

mometasone; nasal

1.2

31.0

7708

53702

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.3

31.0

300

1020

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

30.9

3892

25201

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

30.9

1964

11549

P98

ICPC

Psychosis NOS/other

3.6

30.8

147

318

H81

ICPC

Excessive ear wax

1.5

30.7

1090

5732

N06AB08

ATC

fluvoxamine; oral

2.0

30.6

393

1514

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

30.6

547

2384

D10AX03

ATC

azelaic acid; topical

0.7

30.5

753

8804

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.7

30.4

739

3536

C09DX04

ATC

valsartan and sacubitril; oral

7.5

30.4

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.3

30.4

3670

23635

C07AB05

ATC

betaxolol; oral

3.8

30.4

137

283

W84

ICPC

Pregnancy high risk

1.9

30.3

504

2141

C10AB02

ATC

bezafibrate; oral

15.3

30.3

I50

ICD-10 Finland

Heart failure

7.0

30.2

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.8

30.1

554

2437

C09BA05

ATC

ramipril and diuretics; oral

3.6

30.1

145

317

V03AA01

ATC

3.1

30.0

179

459

N06AA06

ATC

trimipramine; systemic

2.2

30.0

327

1177

SPAT1051

SPAT

Guidance regarding sleep disorders

2.7

29.9

216

625

N06AX26

ATC

vortioxetine; oral

1.6

29.9

941

4812

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

29.9

621

2839

M01AC01

ATC

piroxicam; systemic, rectal

1.4

29.9

1406

7835

L14

ICPC

Leg/thigh symptom/complaint

1.7

29.8

677

3178

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.6

29.8

144

315

G04BD12

ATC

mirabegron; oral

1.7

29.8

668

3122

R06.2

ICD-10 Finland

Wheezing

1.8

29.8

528

2296

SPAT1010

SPAT

Ophthalmoscopy

10.3

29.7

WX872

NOMESCO Finland

Intensive care

2.1

29.7

353

1319

TQW80

NOMESCO Finland

Local dermatologic skincare

2.3

29.7

287

976

T27

ICPC

Fear endocrine/metabol disease other

3.3

29.6

158

374

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

29.6

3699

23909

SFC92

NOMESCO Finland

Other demanding adjuvant procedure of filling therapy

1.6

29.4

786

3855

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.8

29.4

508

2190

J02AC01

ATC

fluconazole; systemic

1.2

29.4

7390

51442

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.4

29.4

114

205

M01AH02

ATC

rofecoxib; oral

1.5

29.3

1223

6654

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

29.3

527

2301

N05AX13

ATC

paliperidone; systemic

3.9

29.3

129

261

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.4

29.3

267

881

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.6

29.3

234

720

V252A

ICD-9 Finland

Contraceptive management, Sterilisation

1.5

29.3

951

4898

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.4

29.2

153

357

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.2

29.2

4216

27702

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

4.1

29.1

119

225

A04

ICPC

Weakness/tiredness general

1.4

29.1

1325

7336

F32.1

ICD-10 Finland

Moderate depressive episode

1.5

29.1

937

4817

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

4.3

29.0

115

211

L72.1

ICD-10 Finland

Trichilemmal cyst

1.6

29.0

737

3567

E000003

ATC

1.7

28.9

605

2774

D01

ICPC

Abdominal pain/cramps general

1.4

28.9

1345

7479

J01FA15

ATC

telithromycin; oral

1.4

28.9

1565

8952

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.1

28.8

366

1405

D10

ICPC

Vomiting

1.5

28.8

947

4895

R03DA04

ATC

theophylline; systemic, rectal

2.0

28.6

376

1464

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

1.9

28.6

441

1825

A02BA04

ATC

nizatidine; systemic

1.6

28.5

708

3408

R4110

NOMESCO Finland

Physiotherapy

1.3

28.3

3092

19639

N05AE03

ATC

sertindole; oral

5.0

28.3

150

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

4.0

28.3

121

239

R74

ICPC

Upper respiratory infection acute

1.2

28.3

5060

34011

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

28.2

402

1616

Z34

ICD-10 Finland

Supervision of normal pregnancy

0.5

28.2

231

3550

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

7.7

28.1

J01CF05

ATC

flucloxacillin; systemic

1.9

28.1

423

1736

F20.8

ICD-10 Finland

Other schizophrenia

4.9

28.0

155

SPD01

NOMESCO Finland

Mucosa-supported complete denture

6.5

27.7

P74

ICPC

Anxiety disorder/anxiety state

1.7

27.7

597

2759

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

27.7

594

2743

L02

ICPC

Back symptom/complaint

1.4

27.7

1214

6671

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.5

27.7

224

695

-1

NOMESCO Finland

1.2

27.7

5355

36263

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

27.7

1212

6658

SPAT1336

SPAT

Request for examination

2.0

27.7

394

1586

L12

ICPC

Hand/finger symptom/complaint

1.4

27.6

1734

10164

L13

ICPC

Hip symptom/complaint

1.4

27.5

1339

7504

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

27.5

907

4687

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

4.2

27.5

111

208

N20.1

ICD-10 Finland

Calculus of ureter

2.1

27.4

347

1330

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.0

27.4

371

1463

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.5

27.3

1124

6095

IEY19

NOMESCO Finland

Psychiatric health counselling and guidance

6.4

27.3

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

7.5

27.2

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.3

27.1

271

938

S94

ICPC

Ingrowing nail

2.9

27.0

174

470

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.5

26.9

1152

6302

N06AX18

ATC

reboxetine; oral

2.7

26.9

190

544

K78

ICPC

Atrial fibrillation/flutter

2.7

26.9

201

595

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.0

26.8

168

446

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

5.2

26.7

133

R52.9

ICD-10 Finland

Pain, unspecified

1.5

26.7

981

5194

R99

ICPC

Respiratory disease other

2.7

26.7

197

580

IGY02

SPAT

3.4

26.7

137

316

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

26.7

563

2587

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

5.1

26.6

137

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

2.3

26.6

268

930

H70

ICPC

Otitis externa

2.3

26.6

266

921

SPAT1202

SPAT

Intra-articular injection

2.4

26.5

246

820

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

3.7

26.5

124

265

U02

ICPC

Urinary frequency/urgency

1.4

26.5

1333

7517

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.2

26.5

145

351

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.0

26.5

359

1416

D82

ICPC

Teeth/gum disease

1.2

26.4

5529

37689

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

5.4

26.4

122

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

2.4

26.4

234

763

63703

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia levis

2.9

26.4

167

447

N48.1

ICD-10 Finland

Balanoposthitis

2.9

26.4

170

459

A62

ICPC

General and Unspecified, Administrative procedure

2.3

26.3

250

843

M01AB01

ATC

indometacin; systemic, rectal

1.8

26.3

470

2050

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.4

26.3

135

311

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.8

26.3

177

493

SPE01

NOMESCO Finland

Mucosa-supported partial denture

3.5

26.3

131

295

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.3

26.3

1932

11608

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

3.4

26.2

133

304

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.8

26.1

468

2042

R04.0

ICD-10 Finland

Epistaxis

1.8

26.0

443

1900

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.2

25.9

264

922

N04BC05

ATC

pramipexole; oral

1.6

25.9

641

3081

E86

ICD-10 Finland

Volume depletion

3.4

25.9

135

315

N06AA04

ATC

clomipramine; systemic

2.3

25.8

249

845

UJD02

NOMESCO Finland

Gastroscopy

1.8

25.8

441

1896

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

25.8

847

4375

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.3

25.8

254

872

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.0

25.7

351

1390

G03DC02

ATC

norethisterone; oral

1.4

25.7

1511

8761

F41.00

ICD-10 Finland

Moderate panic disorder

2.1

25.7

300

1114

G04BD04

ATC

oxybutynin; oral, transdermal

1.9

25.6

413

1740

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.4

25.6

228

744

2959E

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]

6.5

25.6

D02AE01

ATC

carbamide; topical

1.5

25.5

815

4180

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

+∞

25.5

E11.01

ICD-10 Finland

Non-insulin dependent diabetes diabetic coma with hyperglycaemia

+∞

25.5

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

25.5

270

959

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

25.5

1572

9186

IEV99

NOMESCO Finland

Other psychiatric network intervention

4.4

25.5

172

S80.0

ICD-10 Finland

Contusion of knee

1.5

25.5

896

4698

M01AB55

ATC

diclofenac, combinations; oral

1.7

25.4

572

2679

A07AA02

ATC

nystatin; oral

1.7

25.4

560

2606

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

3.3

25.4

136

324

C07BB02

ATC

metoprolol and thiazides; systemic

4.7

25.3

152

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.5

25.3

203

628

I20.00

ICD-10 Finland

Unstable angina

4.3

25.3

100

184

R05

ICD-10 Finland

Cough

1.3

25.2

2188

13460

D01AE15

ATC

terbinafine; topical

1.6

25.2

646

3139

SPA47

NOMESCO Finland

Precision impression for denture

3.0

25.2

155

408

R29

ICPC

Respiratory symptom/complaint other

1.6

25.1

758

3838

R33

ICD-10 Finland

Retention of urine

2.0

25.1

329

1282

R4180

SPAT

22.8

24.9

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

3.6

24.9

117

252

F60.8

ICD-10 Finland

Other specific personality disorders

3.1

24.8

147

377

F20.32

ICD-10 Finland

Undifferentiated schizophrenia stable periodically

6.5

24.8

C08DB01

ATC

diltiazem; oral

2.7

24.7

174

499

F20.5

ICD-10 Finland

Residual schizophrenia

4.8

24.7

139

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

5.1

24.6

126

R07.3

ICD-10 Finland

Other chest pain

1.5

24.6

926

4930

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.3

24.6

1888

11412

H3602, E113

ICD-10 Finland

+∞

24.6

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.0

24.4

320

1246

IEY01

NOMESCO Finland

Psychoeducation, individual

3.1

24.3

140

352

-50

ICPC

Medication/prescr/renewal

1.8

24.3

404

1721

I20.01

ICD-10 Finland

Unstable angina

4.4

24.3

166

D09

ICPC

Nausea

1.7

24.3

518

2390

K05.30

ICD-10 Finland

Periodontitis complex

1.4

24.2

1331

7623

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

1.7

24.2

538

2508

N20.0

ICD-10 Finland

Calculus of kidney

2.4

24.2

216

707

N18.8

ICD-10 Finland

Other chronic renal failure

3.3

24.2

127

299

F20.01

ICD-10 Finland

Paranoid schizophrenia periodically with gradual deterioration

5.3

24.1

116

N03AX11

ATC

topiramate; oral

1.8

24.1

473

2126

L02BG04

ATC

letrozole; oral

1.5

24.1

784

4040

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.3

24.1

129

308

F28

ICD-10 Finland

Other nonorganic psychotic disorders

4.4

24.1

164

SPAT1304

SPAT

Counselling and guidance related to ageing

3.2

24.1

132

321

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.4

24.0

1178

6611

SPAT1395

SPAT

Health check-up of persons outside student and working life

2.0

24.0

336

1344

N06AX17

ATC

milnacipran; oral

2.5

24.0

197

617

OAB48

SPAT

0.7

23.9

1140

11907

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

23.9

455

2028

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

1.9

23.9

394

1674

M79.1

ICD-10 Finland

Myalgia

1.3

23.8

1790

10781

ICB03

SPAT

6.4

23.8

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.8

23.8

410

1767

OAB43

SPAT

0.8

23.7

2818

26265

6663

FHL

Cholecystectomy and cholangiography

3.0

23.7

142

367

S06.0

ICD-10 Finland

Concussion

1.4

23.7

1206

6810

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

6.0

23.6

WX320

NOMESCO Finland

Spinalanesthesy

1.3

23.5

2377

14916

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

23.5

2894

18605

G03FA14

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.6

23.5

520

6218

6423A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Transient hypertension of pregnancy[HYPERTENSIO GRAVIDARUM, ENNEN SYNNYTYSTÄ]

2.2

23.3

240

843

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

23.3

471

2138

OAB72

SPAT

4.3

23.3

166

C09CA08

ATC

olmesartan medoxomil; oral

2.6

23.2

180

548

F10.24

ICD-10 Finland

Alcohol depence active use

2.3

23.2

215

718

N05CD02

ATC

nitrazepam; oral

3.2

23.1

126

305

G04BD08

ATC

solifenacin; oral

1.7

23.1

464

2101

ZXA05

NOMESCO Finland

Left side

1.3

23.1

2484

15705

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

3.7

23.1

106

224

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

23.1

581

2808

M54.3

ICD-10 Finland

Sciatica

1.6

23.0

713

3634

K02

ICD-10 Finland

Dental caries

1.5

22.9

970

5292

K86.3

ICD-10 Finland

Pseudocyst of pancreas

6.5

22.8

TMA00

NOMESCO Finland

Episiotomy

0.5

22.8

158

2559

E03

ICD-10 Finland

Other hypothyroidism

1.6

22.8

671

3377

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

1.9

22.8

370

1564

KH1AD

NOMESCO Finland

CT of urinary organs

1.9

22.8

346

1427

XA420

NOMESCO Finland

Extensive sleep examination

2.8

22.8

154

431

N85.0

ICD-10 Finland

Endometrial glandular hyperplasia

2.1

22.8

275

1039

C10AA02

ATC

lovastatin; oral

3.6

22.7

109

239

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

22.7

2783

17872

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

22.7

1178

6677

L84

ICPC

Back syndrome without radiat pain

1.7

22.6

499

2324

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

2.7

22.6

164

479

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.6

22.5

601

2950

J45.8

ICD-10 Finland

Mixed asthma

1.9

22.5

338

1391

K87

ICPC

Hypertension complicated

4.0

22.5

187

R51.80

ICD-10 Finland

Headache

1.3

22.4

2193

13696

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

4.8

22.4

130

G03DA02

ATC

medroxyprogesterone; systemic (pregnen (4) derivatives)

1.5

22.3

865

4633

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.3

22.3

1640

9842

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.0

22.3

303

1199

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

22.2

497

2325

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

22.2

643

3220

J01CE08

ATC

benzathine benzylpenicillin; parenteral

3.9

22.2

197

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

22.1

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.1

22.1

267

1007

A01AB09

ATC

miconazole; local oral

1.5

22.1

920

4999

M54

ICD-10 Finland

Dorsalgia

1.3

22.0

1592

9527

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.2

22.0

236

847

-31

ICPC

Medical examin/health eval partial

1.6

22.0

649

3268

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.5

21.9

766

4011

Z00.8

ICD-10 Finland

Other general examinations

1.5

21.8

801

4241

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

4.1

21.8

170

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.8

21.8

418

1869

2954A

ICD-9 Finland

Schizophrenic psychoses, Acute schizophrenic episode

4.3

21.7

156

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.4

21.7

185

592

F41

ICPC

Eye, Diagnostic radiology/imaging

33.4

21.7

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

3.2

21.7

122

302

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

21.6

1084

6106

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.5

21.6

176

551

Z30.4

ICD-10 Finland

Surveillance of contraceptive drugs

0.6

21.6

422

5179

H29

ICPC

Ear symptom/complaint other

1.5

21.5

890

4829

K92.1

ICD-10 Finland

Melaena

2.0

21.5

297

1183

F50.8

ICD-10 Finland

Other eating disorders

3.8

21.5

195

D06

ICPC

Abdominal pain localized other

1.4

21.5

937

5140

Z01.2

ICD-10 Finland

Dental examination

1.2

21.4

6416

44930

8113

FHL

Fractional scraping

1.9

21.4

337

1411

D01AC03

ATC

econazole; topical

1.6

21.4

587

2903

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

0.7

21.4

540

6291

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.8

21.4

142

394

R78

ICPC

Acute bronchitis/bronchiolitis

2.1

21.4

250

930

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

2.9

21.3

138

377

8221

FHL

Sterilization of the laparotomy pathway

1.8

21.3

412

1846

WX882

NOMESCO Finland

High dependency care

2.3

21.3

200

673

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

21.2

732

3822

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.2

21.2

235

855

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

21.2

806

4299

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

2.7

21.2

156

461

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

3.4

21.1

106

242

N01

ICPC

Headache

1.3

21.1

1392

8215

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

21.1

832

4473

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

4.0

21.0

172

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

2.6

21.0

162

492

S02CA02

ATC

flumetasone and antiinfectives; otic

1.6

21.0

567

2795

K80.8

ICD-10 Finland

Other cholelithiasis

2.3

20.9

197

663

R05DA01

ATC

ethylmorphine; oral

1.4

20.9

911

4999

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.8

20.9

1329

13342

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.4

20.8

1353

7963

J96.0

ICD-10 Finland

Acute respiratory failure

4.2

20.8

155

M15

ICD-10 Finland

Polyarthrosis

1.8

20.8

347

1480

C10BA06

ATC

rosuvastatin and ezetimibe; oral

4.3

20.8

148

SPAT1244

SPAT

Occupational therapy

3.2

20.8

112

270

R03AC12

ATC

salmeterol; inhalant

1.8

20.7

394

1755

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.1

20.7

252

954

S09

ICPC

Infected finger/toe

2.0

20.7

287

1147

N17

ICPC

Vertigo/dizziness

1.4

20.7

901

4942

F32.8

ICD-10 Finland

Other depressive episodes

2.1

20.6

240

891

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.1

20.6

240

892

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

5.3

20.6

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

20.5

1071

6078

E14.1

ICD-10 Finland

Unspecified diabetes mellitus, with ketoacidosis

42.1

20.4

E78.1

ICD-10 Finland

Pure hyperglyceridaemia

5.2

20.4

D05BB02

ATC

acitretin; oral

2.1

20.4

229

837

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

20.4

1579

9543

SPAT1197

SPAT

Extensive health check-up of expecting family

0.7

20.4

1161

11836

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.7

20.4

416

1897

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

20.3

1624

9857

K29

ICPC

Cardiovascular sympt/complt other

2.1

20.3

238

889

SPAT1235

SPAT

Mental health, emotional support

2.9

20.2

128

345

ZXA10

NOMESCO Finland

Bilateral

1.3

20.2

1738

10662

XF404

NOMESCO Finland

Ambulatory ECG

1.5

20.2

714

3749

SPAT1236

SPAT

Informing family of child’s disability

2.2

20.2

213

758

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.6

20.2

157

479

LCC10

NOMESCO Finland

Supravaginal hysterectomy

3.8

20.2

179

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.5

20.1

745

3952

A11

ICPC

Chest pain NOS

1.6

20.1

590

2968

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

20.0

6012

42044

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.2

20.0

215

773

G44.2

ICD-10 Finland

Tension-type headache

1.3

20.0

1951

12170

L29

ICPC

Musculoskeletal sympt/complt other

1.5

20.0

739

3921

64199

ICD-8 Finland

Abortion induced for other legal indications, Without mention of sepsis or toxaemia

1.5

19.9

813

4400

K29.7

ICD-10 Finland

Gastritis, unspecified

1.9

19.9

317

1333

L30.4

ICD-10 Finland

Erythema intertrigo

2.9

19.9

128

347

Angiography of the heart and coronary arteries

3.4

19.9

100

229

R09

ICPC

Sinus symptom/complaint

1.4

19.8

1175

6810

F50.3

ICD-10 Finland

Atypical bulimia nervosa

3.3

19.8

104

246

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

+∞

19.8

K77

ICPC

Heart failure

7.2

19.8

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

0.7

19.8

682

7510

D01BA02

ATC

terbinafine; oral; topical

1.2

19.8

2759

17949

SFA00

NOMESCO Finland

Small filling

1.3

19.8

1761

10849

AA400

NOMESCO Finland

Electroconvulsive therapy

2.7

19.8

144

423

6420X

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Benign essential hypertension complicating pregnancy, childbirth and the puerperium

3.2

19.7

108

264

EBA10

NOMESCO Finland

Surgical removal of tooth

1.3

19.7

1724

10598

Z28

ICPC

Limited function/disability (Z)

5.1

19.7

100

XX_20

NOMESCO Finland

Bioimpedance measurement

6.6

19.7

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

0.7

19.7

844

8968

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

19.7

994

5606

63701

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Hypertonia

2.6

19.6

147

440

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

19.6

401

1828

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.4

19.6

100

232

A03FA02

ATC

cisapride; oral, rectal

1.5

19.5

640

3306

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

19.5

468

2234

IHZ07

SPAT

4.1

19.5

154

D02

ICPC

Abdominal pain epigastric

1.5

19.5

651

3378

L18

ICPC

Muscle pain

1.7

19.5

393

1784

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

19.5

386

1743

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.0

19.5

275

1107

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.0

19.5

256

1002

SPAT1151

SPAT

Treatment of major wounds

3.4

19.4

221

J96.1

ICD-10 Finland

Chronic respiratory failure

3.5

19.4

217

R4120

NOMESCO Finland

Occupational therapy

1.5

19.4

700

3694

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.7

19.4

420

1950

R41.0

ICD-10 Finland

Disorientation, unspecified

2.6

19.4

145

433

N03AF01

ATC

carbamazepine; oral, rectal

1.6

19.3

522

2571

2961E

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]

5.7

19.3

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

19.3

1078

6188

3051

Kela drug reimbursment

4.2

19.2

138

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

19.2

581

2945

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.8

19.2

132

374

WX704

NOMESCO Finland

Intubation

1.4

19.2

863

4766

R03BB01

ATC

ipratropium bromide; inhalant

2.1

19.2

232

879

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

19.1

5072

35070

SPF10

NOMESCO Finland

Demanding repatation of teeth prosthesis

3.5

19.1

204

K70.0

ICD-10 Finland

Alcoholic fatty liver

4.7

19.1

114

R31

ICD-10 Finland

Unspecified haematuria

1.6

19.1

523

2589

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

1.8

19.0

368

1652

SPAT1241

SPAT

Extensive assessment of psychosocial situation

2.2

19.0

192

670

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

19.0

4801

33059

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

4.8

18.9

108

SPF30

NOMESCO Finland

Soling for prothesis

3.9

18.9

166

K11.2

ICD-10 Finland

Sialoadenitis

1.7

18.9

377

1706

A05

ICPC

Feeling ill

1.5

18.9

682

3602

RD112

NOMESCO Finland

6.0

18.9

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

2.9

18.8

122

333

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

3.2

18.8

104

256

ECB00

NOMESCO Finland

Suture of gingiva

1.8

18.8

366

1643

M01AB08

ATC

etodolac; oral

1.4

18.8

895

4994

TFP20

NOMESCO Finland

Cardiodefibrillation

1.9

18.8

271

1099

D05AX02

ATC

calcipotriol; topical

1.7

18.6

373

1689

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.5

18.6

148

459

G04BD07

ATC

tolterodine; oral

1.8

18.6

335

1468

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

5.0

18.6

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

5.4

18.6

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

26.3

18.5

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.3

18.5

132

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

4.1

18.5

143

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

18.5

2285

14658

OAB74

SPAT

8.9

18.5

IER01

NOMESCO Finland

Psychoeducation, group

2.9

18.5

118

321

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.4

18.4

210

XKD00

NOMESCO Finland

Uroflowmetry

1.6

18.4

556

2816

QBA10

NOMESCO Finland

Incision of skin of trunk

2.6

18.4

139

417

F60.0

ICD-10 Finland

Paranoid personality disorder

3.5

18.4

198

ZX120

NOMESCO Finland

Intravenous

1.4

18.4

919

5172

M76.6

ICD-10 Finland

Achilles tendinitis

1.6

18.4

546

2755

UJK02

NOMESCO Finland

ERCP

2.3

18.4

173

586

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.0

18.3

237

923

Z01.7

ICD-10 Finland

Laboratory examination

1.3

18.3

1248

7398

R25.1

ICD-10 Finland

Tremor, unspecified

2.1

18.3

225

858

L84

ICD-10 Finland

Corns and callosities

1.9

18.2

273

1126

H04

ICPC

Ear discharge

2.0

18.1

248

987

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

4.6

18.1

110

E87.2

ICD-10 Finland

Acidosis

8.2

18.1

F10.09

ICD-10 Finland

Alcohol intoxication UNS

1.9

18.1

260

1055

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

2.1

18.1

219

830

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

1.9

18.1

258

1045

IHZ04

SPAT

3.3

18.0

218

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.6

18.0

134

401

N20.9

ICD-10 Finland

Urinary calculus, unspecified

2.0

18.0

240

946

A02BX02

ATC

sucralfate; oral

1.8

17.9

335

1487

BEF00

SPAT

+∞

17.9

N62

ICD-10 Finland

Hypertrophy of breast

1.5

17.9

666

3538

-69

ICPC

Other reason for encounter NEC

1.7

17.9

375

1723

F33.8

ICD-10 Finland

Other recurrent depressive disorders

2.5

17.9

143

444

WX307

NOMESCO Finland

Obstetric epidural analgesia

0.7

17.9

622

6842

H60.3

ICD-10 Finland

Other infective otitis externa

1.9

17.9

258

1046

B82

ICPC

Anaemia other/unspecified

2.4

17.9

161

533

RS220

NOMESCO Finland

2.4

17.9

163

541

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.5

17.9

140

431

D09AB01

ATC

zinc bandage without supplements; topical

2.3

17.9

174

598

W78

ICPC

Pregnancy

0.8

17.8

1337

13164

Z50.1

ICD-10 Finland

Other physical therapy

1.6

17.8

520

2613

P50

ICPC

Psychological, Medication/prescr/renewal

3.6

17.8

176

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

2.1

17.8

206

768

B37.2

ICD-10 Finland

Candidiasis of skin and nail

3.5

17.8

188

R10.0

ICD-10 Finland

Acute abdomen

1.7

17.7

370

1699

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

0.7

17.7

956

9825

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

10.4

17.7

M75

ICD-10 Finland

Shoulder lesions

1.6

17.7

484

2395

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.8

17.7

288

1223

2957A

ICD-9 Finland

Schizophrenic psychoses, Schizo-affective type

5.2

17.7

D12

ICPC

Constipation

2.0

17.6

231

903

S04

ICPC

Lump/swelling localized

1.4

17.6

966

5526

C09BB04

ATC

perindopril and amlodipine; systemic

2.5

17.6

141

439

J01

ICD-10 Finland

Acute sinusitis

1.5

17.6

719

3896

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

3.2

17.6

235

R52.2

ICD-10 Finland

Other chronic pain

1.7

17.6

384

1789

Z71.9

ICD-10 Finland

Counselling, unspecified

1.5

17.6

644

3410

-1

ICPC

2.4

17.6

156

513

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

2.7

17.5

124

360

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.9

17.5

273

1140

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.8

17.5

155

S74

ICPC

Dermatophytosis

2.2

17.5

180

637

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

2.2

17.5

177

621

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

4.0

17.5

140

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.7

17.4

406

1925

N05AE05

ATC

lurasidone; oral

3.5

17.4

191

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.5

17.4

187

D91

ICPC

Abdominal hernia other

3.0

17.4

104

270

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

4.7

17.4

101

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.6

17.4

473

2336

A11CC03

ATC

alfacalcidol; systemic

2.4

17.3

152

497

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.4

17.3

847

4747

F20.38

ICD-10 Finland

Undifferentiated schizophrenia other definite

5.6

17.3

C09DA02

ATC

eprosartan and diuretics; oral

4.6

17.3

105

A08AA04

ATC

dexfenfluramine; oral

6.2

17.3

B03XA02

ATC

darbepoetin alfa; parenteral

3.0

17.3

104

272

H02AB09

ATC

hydrocortisone; systemic

1.9

17.2

261

1079

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

11.1

17.2

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

17.2

280

1188

F20.08

ICD-10 Finland

Paranoid schizophrenia other definite

4.3

17.2

120

G57.1

ICD-10 Finland

Meralgia paraesthetica

2.2

17.2

178

632

N18.0

ICD-10 Finland

End-stage renal disease

3.9

17.2

150

L30.3

ICD-10 Finland

Infective dermatitis

1.7

17.2

361

1663

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

17.1

454

2228

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

17.1

336

1517

XCK00

NOMESCO Finland

Perimetry

1.6

17.1

510

2579

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.3

17.0

1350

8183

H26.02

ICD-10 Finland

Presenil cataract

1.9

17.0

253

1039

A10BH04

ATC

alogliptin; oral

+∞

17.0

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

4.0

17.0

140

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

2.7

17.0

120

348

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

1.8

17.0

306

1343

N92.4

ICD-10 Finland

Excessive bleeding in the premenopausal period

1.5

17.0

671

3612

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.6

16.9

496

2496

N06AA10

ATC

nortriptyline; systemic

1.8

16.9

289

1248

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

8.2

16.9

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.3

16.9

167

578

250

Kela drug reimbursment

16.8

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.6

16.8

123

364

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.4

16.8

755

4167

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

3.6

16.8

169

WZC00

SPAT

1.6

16.7

480

2402

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

16.7

15862

120487

E78.49

ICD-10 Finland

Other hyperlipidaemia

3.9

16.7

142

K25

ICPC

Fear of hypertension

1.8

16.7

274

1165

F61

ICD-10 Finland

Mixed and other personality disorders

3.0

16.7

100

260

C07AB08

ATC

celiprolol; oral

3.1

16.7

244

G04CA02

ATC

tamsulosin; oral

1.5

16.7

557

2892

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

54.7

16.7

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.0

16.7

249

S19

ICPC

Skin injury other

1.8

16.7

305

1345

KMAK

NOMESCO Finland

1.1

16.7

9043

65768

Z39.2

ICD-10 Finland

Routine postpartum follow-up

0.8

16.6

1267

12455

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

1.9

16.6

238

964

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.1

16.6

188

693

SPA02

NOMESCO Finland

Preparation for dental prosthetics

2.1

16.6

195

732

AA40B

NOMESCO Finland

4.6

16.6

103

-64

ICPC

Encounter/prob initiated by provider

2.4

16.6

149

493

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.3

16.5

162

561

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

16.4

2760

18274

JN4BD

NOMESCO Finland

Extensive body CT

1.4

16.4

781

4358

C10AC01

ATC

colestyramine; oral

1.8

16.4

281

1214

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.6

16.4

123

369

M09AX01

ATC

hyaluronic acid; parenteral

2.0

16.4

220

872

J01DC02

ATC

cefuroxime; systemic

1.4

16.4

797

4466

AN3

Balloon angioplasty and metallic stent

4.1

16.4

126

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

1.7

16.4

382

1813

K76.9

ICD-10 Finland

Liver disease, unspecified

2.3

16.4

161

556

A77

ICPC

Viral disease other/NOS

1.5

16.4

505

2574

F40.1

ICD-10 Finland

Social phobias

1.7

16.3

341

1569

K70.1

ICD-10 Finland

Alcoholic hepatitis

3.6

16.3

165

C02EA02

ATC

3.3

16.3

206

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.9

16.3

235

955

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

3.3

16.2

194

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

16.2

487

2466

2953E

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]

7.1

16.2

N05AX15

ATC

cariprazine; oral

5.3

16.2

E000001

ATC

1.2

16.2

2685

17751

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.2

16.2

220

N91.4

ICD-10 Finland

Secondary oligomenorrhoea

2.8

16.1

107

299

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.0

16.1

202

779

D22

ICD-10 Finland

Melanocytic naevi

0.6

16.1

298

3700

R52.0

ICD-10 Finland

Acute pain

1.6

16.0

382

1824

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.5

16.0

639

3445

H60.1

ICD-10 Finland

Cellulitis of external ear

2.3

16.0

151

512

KBE12

NOMESCO Finland

Transluminal endoscopic extraction of calculus of ureter

3.1

16.0

224

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

16.0

501

2562

ZZA00

NOMESCO Finland

Split skin graft

2.1

16.0

183

677

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

3.0

16.0

239

SPAT1043

SPAT

Audiometry

1.5

16.0

487

2475

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

3.5

16.0

176

K04.00

ICD-10 Finland

Hyperemia of pulp

1.4

16.0

710

3911

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

2.9

15.9

266

XF600

SPAT

4.8

15.9

R4110

SPAT

1.8

15.9

273

1181

LCH11

NOMESCO Finland

Pharmacologic abortion

0.6

15.9

276

3475

A12AA04

ATC

calcium carbonate; oral

2.9

15.9

100

269

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

1.9

15.9

250

1051

SFC00

NOMESCO Finland

Pillar of fillings material

1.7

15.9

309

1393

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

3.1

15.9

221

O81.4

ICD-10 Finland

Vacuum extractor delivery

0.7

15.8

526

5830

U07

ICPC

Urine symptom/complaint other

1.6

15.8

423

2081

G51.0

ICD-10 Finland

Bell palsy

1.8

15.8

263

1127

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.1

15.8

178

657

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

3.4

15.8

178

-56

ICPC

Dressing/pressure/compress/tamponade

2.2

15.8

160

563

S75

ICPC

Moniliasis/candidiasis skin

3.6

15.8

158

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026782) Osmolality of Urine

11781

48626

1.54

319.84

3.1

2.6

551.1

545.1

mosm/kgh2o

1.81

10117

41328

(3051101) Glucose [Moles/volume] in Cord blood

308

30.04

309.39

6.1

1.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3432

9929

2.11

307.69

3.3

2.6

1.4

1.3

3.99

3415

9883

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4588

12911

2.20

307.65

3.5

3.1

1.7

1.8

mmol/l

0.25

3356

9611

(3037467) Urinalysis macro (dipstick) panel - Urine

37164

183466

1.55

307.65

4.9

4.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

16487

47379

2.48

307.65

1.9

1.5

44973140.2

37146052.5

pmol/l

0.61

13755

39504

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

28858

96476

2.53

307.65

2.2

1.8

94.3

97.4

pmol/l

20.45

15924

49450

(3022948) Iron [Moles/volume] in Serum or Plasma

10887

37101

1.91

307.65

2.7

2.2

12.1

14.4

umol/l

4.27

10104

34304

(3004119) Hemoglobin [Mass/volume] in Venous blood

4553

12613

2.23

307.65

3.7

3.0

128.9

130.5

g/l

3.81

4450

12315

(3009261) Glucose [Presence] in Urine by Test strip

27697

131345

1.47

307.65

4.2

3.4

0.0

estimate

8.41

4565

24741

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

27901

128272

1.55

307.65

7.7

6.0

1.2

mmol/l

40.11

23520

108023

(3038515) Glucose [Moles/volume] in Venous blood

1810

3633

3.01

307.65

3.5

3.0

8.6

6.2

mmol/l

155.79

1772

3562

(3014576) Chloride [Moles/volume] in Serum or Plasma

8440

29427

1.82

307.65

8.0

6.7

104.0

104.7

mmol/l

27.92

8269

28820

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

47642

248896

1.74

307.65

5.5

4.5

2.1

mu/l

0.50

43864

229345

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

3750

1091

21.68

307.65

2.1

2.4

85.2

150.5

ug/min

3.14

2250

581

(3024354) Oxygen [Partial pressure] in Venous blood

5614

15644

2.24

307.65

3.6

2.8

4.6

kpa

0.76

5395

15153

(3003458) Phosphate [Moles/volume] in Serum or Plasma

8968

29927

1.91

307.65

6.0

5.0

1.1

1.0

mmol/l

52.42

8399

27798

(3016502) Oxygen saturation in Arterial blood

6848

23813

1.80

307.65

8.7

7.2

95.2

96.0

18.73

6614

22900

(3004775) Volume in Urine collected for unspecified duration

1123

484

13.98

307.65

2.1

2.2

654.3

739.6

3.54

769

368

(44806420)

439

138

18.96

307.65

2.5

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

27399

129988

1.47

307.65

5.7

4.5

0.0

estimate

0.02

5226

24429

(3026008) Bacteria identified in Urine by Culture

18111

73172

1.68

307.65

3.5

2.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

12069

44224

1.78

307.65

1.9

1.7

1189.4

1156.2

nmol/l

3.20

9346

33387

(3012095) Magnesium [Moles/volume] in Serum or Plasma

10199

40408

1.60

307.65

3.6

3.3

0.8

mmol/l

90.21

9572

37620

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

50086

270025

1.72

307.65

5.9

3.8

1.3

1.5

mmol/l

307.65

46309

250814

(3027273) Bicarbonate [Moles/volume] in Venous blood

3894

9514

2.52

307.65

3.6

3.0

25.1

25.4

mmol/l

5.81

3791

9194

(3003396) Base excess in Arterial blood by calculation

7548

26915

1.76

307.65

8.3

6.8

1.0

1.1

mmol/l

0.71

5905

21380

(3000991) Gas panel - Venous blood

5697

18935

1.87

307.65

9.5

7.7

—

(3009508) Creatinine [Moles/volume] in Urine

38324

46220

12.52

307.65

3.6

2.2

7.5

8.0

mmol/l

37.39

31903

39463

(3035350) Ketones [Presence] in Urine by Test strip

27309

129698

1.47

307.65

4.2

3.3

0.0

estimate

0.06

5155

23801

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

51532

276170

1.94

307.65

6.8

4.2

2.5

2.9

mmol/l

307.65

47916

255700

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

52106

242805

3.66

307.65

11.1

3.5

47.0

36.5

mmol/mol

307.65

49332

224189

(3023103) Potassium [Moles/volume] in Serum or Plasma

52697

281268

2.19

307.65

22.2

13.7

4.0

mmol/l

321.22

51565

273595

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

50893

263881

2.16

307.65

7.1

3.7

7.1

5.5

mmol/l

307.65

46835

242751

(3015736) pH of Urine

21782

99844

1.47

307.65

3.9

3.1

5.5

5.8

1.31

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

9577

31320

1.97

307.65

2.7

2.3

20.4

24.0

103.28

8120

26756

(3002032) Base excess in Venous blood by calculation

6878

19188

2.27

307.65

4.2

3.3

1.8

2.0

mmol/l

2.39

5548

15876

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

17910

77383

1.54

307.65

2.3

2.1

221.5

202.0

u/l

1.47

16637

72849

(3027945) Reticulocytes/100 erythrocytes in Blood

7176

25711

1.74

307.65

2.4

2.5

1.9

1.7

43.55

6313

22733

(3044889) 12 lead EKG panel

38169

187598

1.60

307.65

4.4

3.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

15797

60331

1.76

307.65

2.5

2.1

3.2

2.8

mg/l

59.00

13761

51180

(3027801) Oxygen [Partial pressure] in Arterial blood

7549

26919

1.76

307.65

8.3

6.8

11.4

12.9

kpa

113.59

7202

25679

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

7555

26932

1.76

307.65

8.3

6.8

5.1

kpa

4.63

7216

25704

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

24852

117312

1.44

307.65

7.1

5.3

1.2

mmol/l

33.90

22664

106171

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

21578

84978

1.80

307.65

3.5

3.2

35.6

33.1

u/l

3.77

20243

80865

(3019550) Sodium [Moles/volume] in Serum or Plasma

52583

280361

2.18

307.65

22.0

13.6

139.5

139.8

mmol/l

101.13

51515

273236

(3020779) Urea [Moles/volume] in Serum or Plasma

6299

19262

2.05

307.65

8.2

6.3

10.7

8.7

mmol/l

69.95

5981

18313

(3024561) Albumin [Mass/volume] in Serum or Plasma

25942

110711

1.70

307.65

5.2

4.5

35.4

35.8

g/l

21.53

24210

102432

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

3341

785

26.67

307.65

1.1

718.3

12597.5

iu/ml

0.53

698

196

(4146454)

1805

429

25.67

307.65

2.5

1.4

—

(3016750) Collection duration of Urine

764

470

9.74

307.65

2.0

2.2

497.1

498.3

min

0.08

580

361

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

30160

136781

1.64

307.65

6.5

6.0

11.1

11.3

umol/l

0.88

28545

129695

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3592

8780

2.52

307.65

4.3

3.4

48.6

48.5

0.03

3547

8689

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

19171

82406

1.56

307.65

2.8

2.4

54.3

59.8

u/l

12.13

17687

76100

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

41521

207839

1.64

307.65

8.3

7.2

81.9

76.3

u/l

75.01

39198

195881

(1761482) Bacteria [#/volume] in Urine by Culture

2159

4805

2.72

307.65

4.5

3.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

742

200

22.23

307.65

2.0

1.3

137.1

79.5

ug/min

0.62

158

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

18018

67212

1.85

307.65

3.4

2.7

1509.9

1170.9

ng/l

17.13

15190

56997

(3012544) pH of Venous blood

7100

20054

2.25

307.65

4.2

3.3

7.4

1.10

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

40476

208573

1.49

307.65

4.4

3.9

14.9

14.7

pmol/l

91.98

36941

191196

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

3931

1070

23.25

307.65

1.4

2.0

0.9

0.8

nmol/l

7.15

3353

975

(3032080) INR in Blood by Coagulation assay

23949

102245

1.66

307.65

10.2

7.8

1.2

inr

0.86

6919

29706

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

22015

97735

1.54

307.65

4.2

3.2

60.4

56.0

ng/l

0.15

15902

61989

(3009343) pH of Capillary blood

4754

13370

2.20

307.65

3.6

3.1

7.4

3.74

669

1683

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

8919

28355

2.02

307.65

1.8

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

7823

28945

1.69

307.65

1.9

1.6

—

(3012516) Albumin [Mass/volume] in Urine

38150

39869

14.63

307.65

3.6

2.2

153.8

962.6

mg/l

74.92

25568

21415

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4814

13552

2.20

307.65

3.6

3.1

5.2

5.1

kpa

1.18

4468

12466

(3021447) Carbon dioxide [Partial pressure] in Venous blood

6908

19229

2.28

307.65

4.2

3.3

5.8

kpa

0.99

6683

18683

(3020682) Albumin/Creatinine [Ratio] in Urine

40216

41768

16.33

307.65

4.5

2.4

6.4

9.9

mg/mmol

21.45

27202

22157

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

16171

66551

1.61

307.65

1.8

1.6

1.8

1.3

mmol/l

307.65

12994

56862

(3027923) C peptide [Moles/volume] in Serum or Plasma

1108

263

25.40

307.65

1.4

2.5

1.4

1.5

nmol/l

0.61

870

230

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

1912

249

46.96

307.65

1.3

1.8

1.6

1.4

nmol/l

3.08

1764

231

(3004789) Transferrin [Mass/volume] in Serum or Plasma

10192

33871

1.95

307.65

2.7

2.2

2.4

2.3

g/l

71.96

9409

31261

(3026493) Urate [Moles/volume] in Serum or Plasma

18153

66314

1.90

307.65

2.9

2.4

4813.7

3763.3

umol/l

2.44

15707

58057

(3021960) Folate [Moles/volume] in Serum or Plasma

13884

56452

1.60

307.65

1.6

1.5

20.0

20.5

nmol/l

3.70

11986

48537

(3023368) Bacteria identified in Blood by Culture

16725

66103

1.70

307.65

4.6

4.0

—

(3013512) EKG study

17384

71802

1.62

307.65

4.6

3.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

50429

272002

1.75

307.65

6.0

3.9

4.3

4.8

mmol/l

307.65

47043

253462

(3008037) Lactate [Moles/volume] in Venous blood

1906

3894

2.96

307.65

3.4

2.8

1.8

1.4

mmol/l

48.28

1865

3805

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

48910

260318

1.72

307.65

5.4

3.4

1.7

1.2

mmol/l

307.65

44877

240501

(3013826) Glucose [Moles/volume] in Serum or Plasma

36050

148458

2.16

307.65

5.7

4.1

8.0

6.1

mmol/l

307.65

33506

139077

(3000034) Microalbumin [Mass/volume] in Urine

1182

1251

5.69

307.65

3.4

1.8

32.5

54.4

mg/l

1.37

878

790

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6391

22801

1.74

307.44

2.4

2.2

0.2

g/l

0.49

5915

21252

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3365

9702

2.12

304.20

3.3

2.5

0.7

1.22

3243

9277

(3002582) Erythrocytes [#/volume] in Urine

17191

77353

1.45

303.57

3.6

3.0

93.9

88.1

e6/l

0.15

13352

58655

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

47849

258803

1.54

303.45

17.0

11.5

81.0

82.6

ml/min/173m2

42.18

40393

213352

(3022313) Gas panel - Capillary blood

3373

9758

2.11

302.26

3.7

3.2

—

(3000330) Specific gravity of Urine by Test strip

3636

10878

2.04

298.45

3.9

3.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

21434

100652

1.41

298.13

4.5

3.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

6217

22217

1.73

296.63

9.3

7.6

122.5

122.0

g/l

0.88

6029

21384

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

917

1259

4.36

295.70

17.8

18.0

3982.8

2172.5

nmol/l

0.44

882

1192

(3031040) Bacteria [#/volume] in Urine by Automated count

34370

175134

1.40

294.68

5.1

4.1

1875.7

1325.2

e6/l

0.87

585

2250

(3030467) Casts [#/volume] in Urine by Automated count

15836

70696

1.45

288.20

3.5

2.9

0.5

0.4

e6/l

4.86

12103

52461

(3014111) Lactate [Moles/volume] in Serum or Plasma

5833

20688

1.74

284.99

8.1

6.5

1.5

1.3

mmol/l

47.69

5615

19933

(3023520) Reticulocytes [#/volume] in Blood

5429

18870

1.78

284.13

2.5

2.6

75.7

67.3

e9/l

42.66

4161

14123

(3042936) Bacteria identified in Isolate by Culture

8858

35116

1.58

282.26

2.2

1.9

—

(3018095) Leukocytes [#/volume] in Urine

19625

91416

1.41

280.99

4.0

3.5

102.5

89.0

e6/l

1.30

14299

63681

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

863

1204

4.29

273.03

13.3

12.7

2018.3

819.1

nmol/l

0.53

842

1155

(3022689) Creatine [Moles/volume] in Urine

436

284

9.15

270.04

1.4

1.5

—

(3021589) Normoblasts [#/volume] in Blood

24172

117279

1.38

267.79

11.0

9.0

0.0

e9/l

0.23

19926

96230

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

22630

108728

1.38

265.35

2.5

2.2

74.1

910.6

nmol/l

0.50

20408

98470

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

9642

39578

1.53

261.33

1.9

1.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2055

5166

2.40

254.63

3.0

2.7

24.7

24.8

mmol/l

0.48

1825

4492

(3019060) Gas panel - Arterial blood

4500

15274

1.81

253.26

5.3

4.6

—

(3013115) Eosinophils [#/volume] in Blood

27757

138995

1.35

242.16

6.8

6.0

0.2

e9/l

55.11

24274

122616

(3006315) Basophils [#/volume] in Blood

26965

134527

1.35

240.35

6.3

5.8

0.0

e9/l

24.81

23171

116975

(3019198) Lymphocytes [#/volume] in Blood

27545

137879

1.35

240.09

6.5

5.8

2.0

1.9

e9/l

22.45

24129

121960

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

52704

294576

1.65

238.03

13.4

9.4

31.6

25.8

u/l

304.71

51077

284732

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1099

2049

3.22

234.42

2.6

2.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2978

9030

2.00

234.09

5.2

4.9

1.7

0.11

2831

8403

(3001604) Monocytes [#/volume] in Blood

26803

133927

1.34

233.92

6.3

5.8

0.6

e9/l

172.88

23034

116497

(3035285) Chloride [Moles/volume] in Venous blood

1111

2096

3.18

232.64

2.6

2.2

105.3

106.1

mmol/l

5.06

1101

2083

(3041354) Potassium [Moles/volume] in Venous blood

1110

2097

3.17

231.93

2.6

2.2

4.1

4.0

mmol/l

6.78

1100

2085

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2871

8648

2.02

229.70

4.0

3.3

24.7

25.0

mmol/l

6.52

2665

7942

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3271

10326

1.93

229.32

4.7

3.5

23.9

24.4

mmol/l

8.75

2897

9291

(3018418) pH of Serum or Plasma

16523

76729

1.38

228.85

4.4

3.8

7.4

3.11

3373

14263

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4235

14536

1.78

228.74

8.0

6.7

24.5

24.8

mmol/l

3.75

3980

13534

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4832

17251

1.72

227.82

4.1

3.3

97.6

82.9

ng/l

17.41

4150

14879

(3007930) Methemoglobin/Hemoglobin.total in Blood

2914

8879

1.99

225.81

5.3

5.0

0.9

14.48

2767

8267

(3028626) Oxygen [Partial pressure] in Capillary blood

1768

4413

2.41

222.06

2.9

2.6

8.2

kpa

0.03

1644

4083

(3000850) Epithelial cells [#/volume] in Urine

12094

53491

1.43

220.23

2.9

2.4

6.4

5.3

e6/l

12.00

10620

46589

(3013650) Neutrophils [#/volume] in Blood by Automated count

30363

155566

1.33

215.69

10.3

9.0

4.6

4.0

e9/l

307.65

26486

136127

(36304419) Bacteria [Presence] in Urine

15079

69752

1.38

209.85

3.4

2.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

23221

114807

1.33

208.89

3.3

2.6

133.3

126.7

ug/l

2.56

21467

106840

(3034770) Mitochondria Ab [Titer] in Serum

2286

6565

2.10

206.97

1.2

983.9

972.9

titre

0.02

230

(3022217) INR in Platelet poor plasma by Coagulation assay

7910

32552

1.51

206.61

25.8

22.4

1.4

1.3

inr

0.49

1116

4658

(3020564) Creatinine [Moles/volume] in Serum or Plasma

52431

294118

1.57

205.15

21.9

14.1

79.3

75.4

umol/l

98.12

52418

293961

(3007566) Smooth muscle Ab [Titer] in Serum

2308

6679

2.09

204.87

1.2

98.6

133.6

titre

1.40

223

590

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5274

19825

1.63

203.69

3.2

2.6

211.9

186.3

ng/l

3.52

4760

17997

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5876

22716

1.59

202.42

2.2

2.3

361.2

372.7

nmol/l

3.60

5348

20986

(3013707) Erythrocyte sedimentation rate by Westergren method

38080

202464

1.33

201.35

4.4

3.9

15.0

11.0

mm/h

307.65

35251

188190

(3014007) Fractional oxyhemoglobin in Arterial blood

4184

14830

1.72

201.26

10.7

8.6

93.4

94.1

10.66

4166

14775

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4162

14751

1.72

200.21

10.5

8.5

1.4

2.75

4134

14661

(3021901) Oxygen saturation in Capillary blood

1525

3731

2.46

199.59

2.8

2.6

—

(3002030) Lymphocytes/100 leukocytes in Blood

25795

129987

1.31

199.48

6.7

6.0

26.7

28.5

116.25

23932

121423

(3019069) Monocytes/100 leukocytes in Blood

25173

126488

1.31

198.30

6.9

6.2

8.3

8.6

53.42

23497

118785

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4150

14736

1.72

198.23

10.7

8.6

0.7

3.49

4121

14660

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6724

26969

1.54

197.02

1.9

1.7

—

(42870588) Differential panel, method unspecified - Blood

18782

90619

1.34

196.01

6.1

6.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6699

26880

1.54

195.82

1.8

1.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

922

1727

3.19

195.16

1.3

12.2

8.6

mmol/l

7.81

478

(3006504) Eosinophils/100 leukocytes in Blood

25011

125813

1.31

193.78

6.5

6.0

2.8

2.9

11.83

23229

117536

(3018010) Neutrophils/100 leukocytes in Blood

25386

128141

1.31

190.59

6.5

5.8

58.9

56.7

162.08

23624

120202

(3022096) Basophils/100 leukocytes in Blood

24292

121950

1.31

189.42

6.6

6.0

0.6

0.7

42.67

22571

113981

(3041096) Erythrocytes [Presence] in Urine by Automated

15085

70722

1.35

188.77

3.9

3.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

277

155

10.62

188.03

1.3

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

35309

186545

1.31

187.53

4.0

2.8

67.3

43.6

u/l

257.32

32811

175296

(3018677) aPTT in Platelet poor plasma by Coagulation assay

8930

38327

1.45

187.10

2.3

2.0

30.0

29.7

3.57

8668

37182

(1616796) Gas panel - Central venous blood

1783

4826

2.22

186.43

3.8

3.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3047

10044

1.84

186.32

1.8

1.7

1.5

g/l

20.21

2620

8486

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2745

8811

1.89

182.09

2.1

1.9

2.3

2.2

ug/l

0.11

2464

7679

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

49606

276276

1.43

181.16

18.0

12.6

23.8

23.2

mg/l

3.19

42679

215000

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6784

27763

1.51

179.75

3.8

4.5

237.9

245.9

u/l

4.17

6359

26273

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5292

20539

1.58

177.88

2.5

2.2

7.3

7.5

ug/l

0.24

4629

17794

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3931

14166

1.69

177.19

8.4

6.5

24.6

24.9

mmol/l

5.07

3888

14044

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

7818

33121

1.46

173.99

2.0

1.7

1.5

1.4

13.22

6771

29448

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5168

20093

1.57

172.09

4.1

3.5

1.2

mmol/l

4.13

4570

17486

(3040151) Glucose [Moles/volume] in Capillary blood

1008

2177

2.77

167.91

9.5

2.7

8.6

6.2

mmol/l

28.86

810

1813

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

12708

58924

1.35

166.84

2.0

1.7

1.2

mg/l

0.73

9982

44728

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1331

3324

2.40

166.61

1.2

1.3

31.5

36.5

u/l

0.53

1179

2878

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1429

3694

2.32

165.89

3.1

3.0

0.9

0.8

nmol/l

4.98

1106

2828

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4625

17784

1.59

160.84

1.7

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1643

4579

2.16

159.86

3.5

2.5

37.4

33.0

umol/l

7.75

1405

3874

(3018405) Lactate [Moles/volume] in Arterial blood

2459

7963

1.86

158.33

4.7

3.9

1.6

1.3

mmol/l

24.44

2408

7838

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1069

2484

2.58

155.09

1.3

21.6

33.7

nmol/l

—

(3020891) Body temperature

2733

9235

1.79

153.55

5.7

4.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

24635

126136

1.27

152.16

4.4

3.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

7037

29920

1.45

151.81

3.0

2.6

9.3

8.2

umol/l

2.86

6008

25967

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

9707

43698

1.38

151.29

3.0

2.6

1.6

1.1

e6/l

1.32

5688

24288

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

10902

50052

1.36

150.04

4.3

3.4

475.4

488.2

ng/l

0.09

8508

37248

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3781

14072

1.63

149.74

1.6

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3433

12469

1.67

149.37

10.9

8.8

24.2

24.4

mmol/l

4.02

3160

11712

(3029937) Albumin [Presence] in Urine by Test strip

14627

70176

1.31

148.84

4.7

3.8

0.0

estimate

0.34

4948

23693

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2295

7423

1.86

148.14

3.4

2.9

0.4

0.3

u/ml

0.25

1327

4170

(3044640) Blood type and Crossmatch panel - Blood

17113

83977

1.29

146.71

2.6

2.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

4918

19576

1.53

146.30

2.1

2.7

66.8

66.5

g/l

1.48

4468

17773

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1044

2499

2.50

142.71

1.1

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

16698

82131

1.29

138.69

4.5

4.7

2.6

3.4

ug/l

4.06

14814

74445

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3178

29313

0.62

137.01

2.1

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3471

12929

1.63

136.57

11.5

9.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

12831

61039

1.31

136.56

4.1

3.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

17960

89282

1.28

136.55

3.3

3.4

2.4

mmol/l

31.57

15744

78079

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6022

25343

1.45

135.95

3.8

3.1

—

(3010421) pH of Blood

1935

6087

1.91

135.65

4.4

3.3

7.4

7.39

1664

5137

(40767503) Oxygen content in Capillary blood by calculation

1626

4811

2.03

135.44

2.8

2.2

16.6

16.5

0.13

919

2291

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2089

6767

1.86

134.01

1.5

1.4

256.7

288.2

ug/g

8.26

1218

3869

(3017181) Myelocytes/100 leukocytes in Blood

5246

21545

1.48

133.90

4.0

4.1

0.9

1.0

0.50

1560

5863

(3019150) Specific gravity of Urine by Refractometry

11987

56648

1.32

133.20

4.8

3.7

1.0

kg/l

0.03

2047

8080

(21494755) Public health laboratory ask at order entry panel

3541

31639

0.64

131.86

1.4

1.3

—

(3027315) Oxygen [Partial pressure] in Blood

1721

5288

1.95

129.09

4.5

3.4

8.6

8.7

kpa

0.34

1677

5166

(3013290) Carbon dioxide [Partial pressure] in Blood

1708

5254

1.95

127.69

4.5

3.4

5.0

kpa

1.10

1664

5133

(3012501) Base excess in Blood by calculation

1706

5254

1.95

127.10

4.5

3.4

2.7

2.4

mmol/l

2.99

1135

3569

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1928

19741

0.56

125.60

1.6

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

8925

40727

1.35

124.74

3.1

2.8

3.4

2.8

e6/l

4.60

4943

21488

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1499

4457

2.02

123.14

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

125

26.48

121.83

1.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

641

1293

2.96

120.34

3.4

3.5

32.8

27.6

mu/l

2.00

602

1242

(3004588) Protein electrophoresis panel - Serum or Plasma

4044

16067

1.53

120.22

2.0

2.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

2080

6966

1.80

119.82

5.1

4.1

3.9

3.8

mmol/l

9.13

1953

6596

(3021440) Promyelocytes/100 leukocytes in Blood

4948

20511

1.47

119.80

4.1

4.2

0.1

0.10

1444

5412

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2027

6810

1.79

115.50

2.3

3.8

6.2

3.2

ratio

0.45

162

542

(3034860) Kappa light chains.free [Mass/volume] in Serum

2079

7041

1.78

115.34

2.4

3.8

83.7

53.2

mg/l

0.55

1645

5729

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2076

7032

1.77

115.11

2.4

3.8

43.2

42.1

mg/l

0.13

1634

5732

(40761511) CBC panel - Blood by Automated count

50917

288646

1.36

114.78

17.8

11.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

3734

14781

1.53

112.60

1.6

2.0

1.2

1.4

g/l

2.95

3372

13526

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1938

6521

1.79

109.80

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1638

5229

1.88

109.66

2.4

2.0

130.6

131.0

g/l

0.21

1260

3668

(3002179) Metamyelocytes/100 leukocytes in Blood

4706

19662

1.45

108.86

3.9

4.0

0.6

0.7

0.20

1109

4269

(3033658) Prothrombin time (PT) actual/Normal

13853

68367

1.26

105.48

4.7

3.7

90.6

91.4

2.62

13401

66680

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3543

14133

1.52

102.78

1.8

1.6

—

(3020491) Glucose [Moles/volume] in Blood

687

1572

2.61

102.74

2.2

1.4

8.1

6.0

mmol/l

35.06

459

1193

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

6055

47113

0.73

102.56

1.4

1.5

—

(3025159) Blasts/100 leukocytes in Blood

4615

19431

1.44

102.18

4.1

4.2

0.1

0.2

0.57

1211

4615

(3011985) Renin [Units/volume] in Plasma

1114

3176

2.10

102.16

1.4

1.5

77.4

55.9

mu/l

1.95

1004

2835

(40768797) Stomach Pathology biopsy report

7973

36833

1.33

100.17

1.3

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2285

8265

1.66

100.05

2.6

2.2

866.8

449.6

ug/l

1.77

2162

7689

(3005719) IgG [Mass/volume] in Serum or Plasma

4580

19365

1.43

98.98

2.4

2.8

10.6

10.5

g/l

0.43

4176

17745

(40760888) Immunoglobulin light chains.free panel - Serum

1600

5243

1.83

98.69

2.4

3.9

—

(3020876) Protein [Mass/time] in 24 hour Urine

680

1602

2.53

96.04

1.8

2.0

0.8

0.9

g/24h

0.32

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3238

12876

1.52

95.09

2.9

2.6

0.4

0.3

e6/l

2.04

3168

12460

(3000494) Fungus identified in Specimen by Culture

6718

30609

1.34

92.07

1.5

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1026

2955

2.07

91.66

1.3

1.4

295.6

304.3

pmol/l

0.23

807

2285

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

241

290

4.93

90.20

3.1

1.3

8.2

6.4

mmol/l

5.47

132

194

(3017817) Protein [Mass] in Urine collected for unspecified duration

705

1749

2.40

89.50

2.3

2.6

0.5

0.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

1184

3634

1.95

88.93

2.0

1.7

1.9

1.7

mmol/l

11.15

1155

3546

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1742

6094

1.71

86.12

3.1

2.7

1.7

1.4

mg/l

37.92

1579

5626

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

28399

183258

0.84

85.99

2.8

3.0

—

(3022621) pH of Urine by Test strip

3911

16480

1.43

85.55

3.4

2.7

—

(40758558) Short blood count panel - Blood

13554

68027

1.23

85.22

7.4

6.9

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

12846

64119

1.24

84.97

2.6

2.2

—

(40761536) Microorganisms panel - Urine sediment

4963

21994

1.37

80.74

4.5

3.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6922

32242

1.31

80.33

8.6

6.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1327

4393

1.81

79.15

3.5

2.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

467

1004

2.77

78.60

1.7

1.6

20.3

2.9

nmol/l

0.84

401

830

(3047181) Lactate [Moles/volume] in Blood

2029

7621

1.60

76.23

6.6

5.5

1.5

1.2

mmol/l

25.10

1804

6734

(3024928) Oxygen saturation in Venous blood

1389

4718

1.76

76.06

3.9

2.9

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4731

21047

1.36

74.81

2.8

2.5

63.5

68.9

ml/min/173m2

12.17

1959

8019

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1929

7194

1.61

74.61

1.8

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2689

10815

1.49

74.37

1.5

1.6

17.8

14.4

u/ml

0.34

317

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1050

3300

1.90

73.60

1.1

1.5

g/l

1.30

955

2980

(3009466) Valproate [Moles/volume] in Serum or Plasma

1131

3657

1.85

72.71

6.0

5.0

367.1

369.8

umol/l

0.24

999

3151

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3606

28918

0.72

71.77

1.9

2.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

660

1759

2.23

71.47

1.1

284.8

460.6

mg/l

0.53

585

1591

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1073

3442

1.86

70.70

1.3

0.2

0.3

nmol/l

2.19

199

(3051387) C reactive protein [Mass/volume] in Capillary blood

1441

5065

1.70

69.97

3.9

3.1

26.6

26.8

mg/l

0.06

990

3033

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1068

3463

1.84

68.07

1.3

1.2

nmol/l

0.03

1033

3335

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

985

3112

1.89

67.99

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

40967

229848

1.19

67.55

22.2

15.1

14.0

13.6

281.79

40074

225145

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1353

4732

1.71

66.89

1.3

1.2

211.7

115.6

titre

0.51

100

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

9628

47633

1.24

66.60

3.0

2.5

2.4

mmol/l

61.75

8349

41618

(3022806) Fractional oxyhemoglobin in Capillary blood

947

2990

1.89

65.50

2.0

1.6

89.5

89.9

1.33

934

2938

(40761535) Cells panel - Urine sediment

4632

20950

1.34

65.26

3.9

3.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

6763

32222

1.27

64.75

5.8

3.9

30.4

32.3

38.00

4798

22241

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

169

200

5.01

64.51

1.3

1.5

5.8

7.3

nmol/l

0.33

164

187

(40760892) CBC W Ordered Manual Differential panel - Blood

11914

60530

1.21

62.84

5.1

4.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

6255

29615

1.28

62.84

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5679

26655

1.29

60.96

3.7

4.1

24.7

24.9

ug/l

0.01

4689

21097

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

980

3210

1.82

60.51

2.8

2.5

567.2

552.0

u/ml

0.01

955

3089

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

5291

24631

1.30

60.43

2.8

2.3

50.0

43.6

u/l

0.19

4416

21324

(3037121) Protein [Mass/volume] in Urine

2087

8323

1.50

59.93

3.2

3.0

0.4

0.3

g/l

2.74

982

3443

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2117

8491

1.49

59.14

1.6

274.5

269.7

titre

0.02

372

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3298

25920

0.74

56.75

1.8

1.9

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1412

5223

1.61

56.39

1.6

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

107

7.05

55.59

2.0

4.2

0.9

0.7

mmol/l

0.44

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3089

13436

1.38

55.59

2.5

2.4

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

533

1450

2.19

55.10

13.1

11.9

0.6

mmol/l

1.46

499

1319

(1761868) Lipid panel - Serum or Plasma

19116

102012

1.16

54.93

4.0

2.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1855

15926

0.68

54.08

1.8

1.9

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2217

9184

1.45

52.53

1.9

2.4

7.8

7.2

g/l

42.08

1601

6934

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2213

9173

1.44

52.27

1.9

2.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2207

9157

1.44

51.85

1.9

2.4

4.0

3.8

g/l

8.11

1532

6582

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2076

8540

1.45

51.01

1.9

2.4

10.1

10.3

g/l

1.33

1743

7069

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

11141

57203

1.19

50.58

1.3

1.2

1.5

1.7

u/ml

0.73

3034

15665

(21494890) Protein electrophoresis panel - 24 hour Urine

712

2230

1.90

50.55

1.6

2.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

9867

50172

1.20

49.83

1.5

1.4

2.7

2.3

g/l

56.41

6079

31097

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

900

3050

1.76

49.74

6.9

5.9

11.6

11.3

mg/l

0.87

820

2805

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

342

800

2.54

49.27

2.4

2.5

158.9

149.5

nmol/l

0.56

294

698

(3026692) Albumin [Mass/volume] in Peritoneal fluid

236

452

3.10

48.60

1.4

1.3

12.8

13.4

g/l

0.36

185

338

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1013

3581

1.69

48.22

1.4

1.3

9.6

6.4

mmol/l

95.86

760

2602

(3035637) Corticotropin [Mass/volume] in Plasma

880

3008

1.74

47.24

1.6

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

12746

66521

1.17

47.05

4.0

4.1

23.0

21.4

20.39

5686

31116

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1430

12535

0.67

46.32

1.7

1.8

—

(3037756) Immunofixation for Serum or Plasma

1282

4868

1.57

45.94

1.4

1.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

665

2104

1.88

45.85

1.2

1.3

—

titre

—

(3037522) Nuclear Ab [Titer] in Serum

7544

37663

1.21

45.83

1.3

1.4

438.4

572.5

titre

8.56

1463

7745

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2576

11264

1.37

44.70

2.1

2.0

38.3

39.9

u/l

3.02

2207

10150

(3039000) Anion gap in Blood

1392

5419

1.53

44.70

7.8

6.4

11.7

10.9

mmol/l

13.71

1273

4869

(3018572) Chloride [Moles/volume] in Blood

1392

5420

1.53

44.66

7.8

6.4

104.9

105.3

mmol/l

2.24

1273

4871

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1693

6875

1.47

44.42

1.4

1.5

20.7

13.5

iu/ml

0.79

169

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

416

1118

2.21

44.40

1.2

1.3

4.9

4.5

umol/l

0.98

382

1027

(3023487) Leukocytes [#/volume] in Peritoneal fluid

305

711

2.55

44.31

2.0

1.8

3546.2

4369.5

e6/l

0.11

221

464

(3003181) Sodium [Moles/volume] in Urine

1092

4035

1.61

43.85

1.4

60.2

63.7

mmol/l

1.85

828

3208

(3042733) HLA Ab [Presence] in Serum

292

672

2.58

43.52

4.7

4.9

—

(40768441) Liver Pathology biopsy report

567

1733

1.95

43.31

1.5

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2096

8911

1.41

42.99

3.3

3.5

2299.2

1690.8

u/ml

0.17

1814

7579

(3026250) Tacrolimus [Mass/volume] in Blood

343

859

2.37

42.97

38.2

32.7

7.4

7.3

ug/l

0.32

321

759

(3012565) Volume of 24 hour Urine

406

1100

2.19

42.53

2.1

2.2

1971.3

2007.5

0.27

347

1009

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1159

10408

0.65

42.29

1.4

—

(4010399)

4114

19426

1.27

41.29

1.5

1.4

—

(3007461) Platelets [#/volume] in Blood

53326

309439

1.25

41.25

28.0

18.3

254.4

252.2

e9/l

11.08

52095

301569

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

835

2932

1.70

40.81

2.0

2.3

32.1

32.8

4.33

824

2912

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3637

27055

0.78

40.77

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

590

1870

1.88

40.53

2.1

1.9

2.0

2.3

u/field

0.62

225

910

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1341

5291

1.51

40.49

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1341

5293

1.51

40.42

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

272

629

2.57

40.21

1.9

1.7

13587.9

11943.5

e6/l

0.09

161

319

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2399

10560

1.36

39.87

2.1

1.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1766

7409

1.42

39.02

1.4

1.3

9.1

11.1

u/l

8.98

1435

6138

(3035941) MCH [Entitic mass]

53333

309682

1.24

38.88

27.8

18.2

30.0

30.4

292.96

52620

305519

(3052851) Hemolysis interference index of Serum or Plasma

1838

7776

1.41

38.75

3.7

3.0

—

(3024731) MCV [Entitic volume]

53337

309729

1.24

38.63

27.9

18.2

90.6

91.1

102.00

52627

305550

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2200

9601

1.37

38.59

1.9

1.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1430

5782

1.48

38.36

1.6

—

(3026361) Erythrocytes [#/volume] in Blood

53336

309752

1.24

38.28

28.0

18.3

4.5

e12/l

73.60

51948

301051

(3010813) Leukocytes [#/volume] in Blood

53341

309809

1.24

37.99

28.0

18.3

7.4

6.5

e9/l

307.65

51949

301099

(3019832) Treponema pallidum Ab [Presence] in Serum

3066

23075

0.77

37.65

1.7

1.6

—

(3000963) Hemoglobin [Mass/volume] in Blood

53341

309853

1.23

37.48

28.1

18.4

135.7

136.0

g/l

5.59

52665

305659

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1253

4963

1.51

37.17

3.3

1125.6

604.0

u/ml

0.51

1142

4487

(3017569) Oxygen content in Arterial blood

355

963

2.19

37.16

2.1

2.2

—

(3036603) Volume of Urine

511

1591

1.91

37.08

1.7

1.6

1798.7

2064.8

2.69

167

279

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2023

8785

1.38

36.58

1.9

2.4

3.1

3.0

g/l

2.85

1572

6763

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1236

10628

0.68

36.11

1.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

125

191

3.88

35.76

7.0

6.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1085

4205

1.54

35.62

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1373

5591

1.46

35.56

1.6

1.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

1034

3981

1.55

34.97

3.0

3.4

1.3

1.5

1.40

787

3096

(40757494) Bilirubin.total [Moles/volume] in Blood

408

1202

2.02

34.65

2.1

32.2

21.0

umol/l

0.52

119

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

948

3588

1.57

34.55

1.4

—

(3019977) pH of Arterial blood

408

1219

1.99

33.37

2.6

2.5

7.4

2.88

152

419

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1069

4193

1.52

33.25

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

201

442

2.70

32.83

2.7

2.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1605

6834

1.40

32.64

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1018

3969

1.53

32.56

1.5

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

495

1595

1.84

32.45

1.7

1.5

28.8

22.0

u/ml

1.81

106

312

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1072

4234

1.51

32.29

1.5

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1665

7159

1.39

31.97

2.2

2.1

11.9

10.5

mg/l

3.95

1546

6709

(3033799) Differential panel - Peritoneal fluid

252

629

2.38

31.97

2.2

1.7

—

(3019225) pH of Specimen

5190

25815

1.21

31.93

4.7

3.8

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

445

4699

0.56

31.90

1.5

1.4

—

(3019230) Fractional oxyhemoglobin in Venous blood

1033

4063

1.51

31.74

4.1

2.5

65.3

64.3

0.76

1027

4050

(3043238) Trisomy 21 risk [Likelihood] in Fetus

462

4816

0.56

31.60

1.5

—

(3005033) Fetal Nuchal fold Thickness US

446

4693

0.56

31.57

1.5

1.4

—

(3025941) Bacteria identified in Stool by Culture

3277

15565

1.26

31.07

1.3

1.2

—

(3022145) Colonoscopy Study observation

6077

30782

1.19

30.58

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1812

7967

1.36

30.32

2.0

2.6

0.7

0.9

g/l

3.00

1548

6811

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1665

7233

1.37

30.05

1.8

2.3

37.1

38.1

g/l

7.33

1420

6184

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

824

3121

1.57

30.00

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

341

994

2.04

29.89

2.0

1.9

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1618

7012

1.38

29.64

1.9

2.4

0.0

g/l

0.10

1462

6410

(3003129) Base excess in Capillary blood by calculation

218

529

2.44

29.41

1.7

0.0

0.9

mmol/l

2.18

205

497

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1147

4686

1.46

29.27

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

646

6069

0.63

29.10

1.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

191

437

2.59

29.01

1.3

23.3

27.2

g/l

2.18

150

334

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

986

3927

1.49

28.59

1.2

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1499

6472

1.38

28.11

1.9

2.4

0.0

g/l

0.11

1350

5889

(40768446) Kidney Pathology biopsy report

282

783

2.14

28.05

1.7

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

835

3223

1.54

28.02

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

479

1606

1.77

27.71

1.2

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1478

6386

1.38

27.60

1.9

2.4

0.0

g/l

0.00

1346

5874

(3006270) Folate [Moles/volume] in Blood

570

2023

1.67

26.98

1.2

356.4

371.1

nmol/l

0.79

428

1808

(3037556) Urate [Mass/volume] in Serum or Plasma

238

629

2.24

26.68

1.4

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

621

5743

0.64

26.10

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

851

3354

1.51

25.99

1.4

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

622

5738

0.64

25.85

1.4

—

(3004451) EKG impression Narrative

342

1054

1.93

25.77

1.2

—

(3044927) Protein electrophoresis panel - Urine

607

2217

1.63

25.76

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

518

1818

1.69

25.58

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

622

5722

0.64

25.52

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

618

2273

1.62

25.51

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

620

5699

0.64

25.35

1.4

—

(3027035) Albumin [Mass/time] in 24 hour Urine

141

3.78

25.07

1.4

1.5

160.6

383.7

mg/24h

0.49

(3000012) Reticulocyte production index

386

1252

1.83

24.94

1.4

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

7289

38076

1.15

24.45

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

575

2100

1.63

24.44

1.5

1.4

promille

0.42

443

1627

(3003434) Protein [Mass/volume] in Pleural fluid

765

2988

1.52

24.40

1.5

1.4

32.1

33.9

g/l

3.51

685

2714

(3026389) Candida sp identified in Specimen by Organism specific culture

918

3731

1.46

24.15

1.4

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1314

5694

1.37

24.15

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

560

5195

0.63

23.91

1.6

1.5

—

(3044007) Cell count panel - Peritoneal fluid

220

591

2.21

23.81

2.2

1.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2203

16344

0.79

23.74

1.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

811

6972

0.68

23.73

1.5

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1946

8962

1.29

23.62

1.7

341.0

298.4

mu/l

1.59

1755

8149

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3487

17170

1.21

23.57

3.2

3.4

4.4

4.5

pmol/l

4.87

3054

15357

(3006576) Bicarbonate [Moles/volume] in Blood

266

774

2.04

23.57

6.9

5.8

25.0

25.3

mmol/l

0.56

249

694

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

600

2246

1.59

23.10

3.0

2.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

340

1087

1.86

23.03

3.0

3.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

536

1954

1.63

22.98

2.0

1.9

17.6

17.8

nmol/l

0.19

506

1850

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1007

4217

1.42

22.63

1.6

1.7

—

(40762365) Oxygen content in Arterial blood by calculation

149

343

2.57

22.50

3.4

2.7

14.8

14.9

ml/dl

0.08

137

321

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

409

1395

1.74

22.44

1.3

50.4

84.7

titre

1.33

132

(3006922) Hepatitis E virus Ab [Presence] in Serum

503

1819

1.64

22.28

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1178

5083

1.38

22.25

6.4

5.4

699.1

2137.1

iu/ml

0.83

207

699

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1859

8579

1.29

22.22

2.7

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

146

335

2.58

22.19

2.5

65.2

26.9

mg/l

1.30

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1676

7635

1.31

22.08

3.0

2.5

3.8

3.6

g/l

6.03

1592

7271

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

417

1442

1.72

21.82

1.3

528.9

361.5

titre

0.37

(3049717) Cytology report of Urine Cyto stain

2043

9589

1.27

21.37

2.7

2.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1235

5419

1.36

21.04

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

434

1537

1.68

20.85

1.4

—

(3045414) Leukocytes [Presence] in Urine

2475

11924

1.24

20.64

2.0

1.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

411

1439

1.70

20.61

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

560

2124

1.57

20.46

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

323

1057

1.81

20.40

2.0

1.8

114.8

133.6

umol/l

0.52

171

528

(3051611) Lipemic interference index of Serum or Plasma

661

2603

1.51

20.39

3.9

3.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

140

329

2.52

20.35

1.6

1.2

mmol/l

0.08

135

314

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

719

2887

1.48

20.20

3.9

3.1

15.0

5.5

nmol/l

0.65

688

2810

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

425

1510

1.67

20.20

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

199

553

2.13

19.94

1.2

410.3

308.7

pmol/l

0.62

143

409

(3009542) Hematocrit [Volume Fraction] of Blood

44223

255505

1.10

19.76

20.1

13.3

39.2

40.2

66.34

29118

193084

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

128

292

2.60

19.74

3.3

2.3

85.7

59.5

pmol/l

0.76

111

252

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

672

2677

1.49

19.64

1.6

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

128

293

2.59

19.62

5.2

4.8

41.5

43.2

ug/min

0.13

105

216

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

398

1404

1.68

19.45

1.4

1.3

6.5

5.5

mmol/l

40.71

359

1342

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

732

2980

1.46

19.21

1.7

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

453

1674

1.61

18.52

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

548

2121

1.53

18.38

1.3

7.5

5.5

mmol/l

30.97

507

1954

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

529

2032

1.55

18.35

1.3

357.4

538.1

u/l

2.35

503

1922

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

454

1684

1.60

18.29

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

145

366

2.35

18.22

1.7

1.2

mmol/l

0.35

139

351

(3008295) Osmolality of Serum or Plasma

599

2373

1.50

18.03

1.4

1.5

281.6

277.7

mosm/kgh2o

3.03

457

1865

(3024932) HLA-DR beta [Type]

242

752

1.91

18.00

1.1

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

200

585

2.03

17.64

1.4

1.3

17.5

16.7

umol/l

1.25

179

517

(3024471) HLA-A [Type]

245

772

1.88

17.50

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1686

7940

1.26

17.21

1.3

—

(3017704) Immunofixation for Urine

347

1223

1.68

17.09

1.3

1.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1376

6324

1.29

17.06

1.6

15734.9

12310.5

e6/l

1.61

990

4595

(3013727) Leukocytes other/100 leukocytes in Blood

231

720

1.90

17.06

3.4

3.7

55.7

51.6

2.01

221

699

(1002224) Polysomnography panel

2506

12337

1.21

16.96

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

656

2687

1.45

16.76

1.2

58.5

64.2

u/l

1.04

435

1804

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1272

5800

1.30

16.74

2.0

1.9

166.9

204.4

pmol/l

27.88

1193

5535

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2091

10148

1.23

16.32

1.1

22.5

5.2

u/ml

0.61

167

(3017315) Amylase [Enzymatic activity/volume] in Urine

382

1399

1.62

16.27

1.4

1.2

200.9

359.5

u/l

3.50

352

1310

(3044941) Cell count panel - Synovial fluid

926

4051

1.36

16.20

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

883

3835

1.37

16.17

2.8

2.5

3155.6

5120.0

u/ml

0.25

216

(3023199) Leukocytes [#/volume] in Pleural fluid

659

2722

1.44

16.13

1.5

1.4

2945.3

3506.3

e6/l

0.31

454

1994

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

8955

48519

1.11

15.95

2.8

2.9

0.7

0.8

ug/l

0.49

5865

30669

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

215

671

1.90

15.86

2.7

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

215

671

1.90

15.86

2.7

2.5

—

(44806118)

651

2692

1.44

15.85

1.5

1.6

—

(44790049)

651

2693

1.44

15.81

1.5

1.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

597

2430

1.46

15.79

1.5

28.6

32.2

1.55

378

1486

(44790047)

651

2694

1.44

15.78

1.5

1.6

—

(44790048)

651

2694

1.44

15.78

1.5

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

276

934

1.75

15.75

3.0

2.8

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

166

473

2.08

15.74

8.6

7.8

—

(3036525) Urea [Moles/time] in 24 hour Urine

3.77

15.70

3.1

2.8

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

446

1711

1.55

15.65

3.6

3.2

152.9

123.0

nmol/l

0.74

441

1680

(3025130) Human papilloma virus identified in Specimen

462

4070

0.67

15.55

1.6

1.7

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

184

548

1.99

15.52

8.6

7.9

—

(3047189) Immunofixation for 24 hour Urine

299

1041

1.70

15.46

1.4

2.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1705

8144

1.25

15.44

1.8

1.7

32.8

42.7

nmol/l

56.24

1645

7961

(4034850)

1816

8745

1.24

15.27

12.5

8.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1124

5115

1.31

15.06

1.5

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

167

488

2.03

14.86

1.3

148.5

51.7

mu/l

1.36

123

362

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

384

1444

1.58

14.73

2.6

1.9

93.9

99.5

2.06

374

1331

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

519

2090

1.47

14.54

1.2

120.6

196.1

titre

1.83

371

(3012441) Differential panel - Pleural fluid

573

2354

1.44

14.49

1.5

1.4

—

(3045716) Anion gap in Serum or Plasma

294

1039

1.68

14.44

2.2

2.3

9.8

8.7

mmol/l

4.59

228

742

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

517

2086

1.47

14.36

1.2

112.3

201.7

titre

1.13

(3023419) Bacteria identified in Sputum by Culture

735

3165

1.38

14.26

2.3

2.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

289

1023

1.68

14.12

2.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

562

4688

0.71

14.06

2.0

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

6267

33521

1.12

14.01

2.2

2.4

150.1

130.2

ug/g

3.52

4933

26381

(3010726) Horse dander IgE Ab [Units/volume] in Serum

543

4551

0.70

13.97

1.1

1.8

u/ml

0.05

153

1038

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

350

1306

1.59

13.91

1.5

—

(3042631) Mycobacterium sp identified in Specimen

794

3479

1.36

13.84

2.4

2.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

608

2548

1.42

13.83

2.8

3.4

59.9

57.9

1.23

375

1665

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1106

5083

1.29

13.81

1.4

16.3

21.6

u/ml

0.77

(3028308) Erythrocytes [#/volume] in Pleural fluid

591

2478

1.42

13.43

1.5

1.4

41969.6

60939.8

e6/l

1.20

334

1502

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

350

1319

1.57

13.37

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

139

395

2.09

13.36

2.5

2.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

253

878

1.71

13.32

1.5

1.4

15.2

14.9

pmol/l

0.21

205

736

(3008757) Leukocyte morphology finding [Identifier] in Blood

644

2746

1.39

13.29

3.2

3.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

467

3981

0.69

13.27

1.1

4.1

3.9

u/ml

0.10

195

1474

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

164

2.74

13.17

2.8

2.0

63.2

57.9

0.48

100

(3014271) Vancomycin [Susceptibility]

320

1185

1.60

13.16

3.0

2.9

—

(3016038) Potassium [Moles/volume] in Urine

392

1529

1.52

12.88

1.2

34.0

34.8

mmol/l

0.26

324

1312

(3024980) IgG subclass 4 [Mass/volume] in Serum

953

4336

1.31

12.87

1.6

1.5

0.8

g/l

0.21

700

3276

(3045788) Cell count panel - Pleural fluid

510

2099

1.44

12.85

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

368

3259

0.67

12.83

1.0

0.6

0.5

u/ml

0.13

671

(3042111) Morphology [Interpretation] in Bone marrow Narrative

886

3994

1.32

12.79

1.5

1.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

730

5750

0.75

12.68

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1410

10248

0.81

12.67

1.9

1.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

995

4567

1.29

12.59

1.3

1.2

304.8

268.4

u/ml

3.12

613

3033

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

780

3465

1.34

12.48

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

1238

5849

1.26

12.42

2.3

2.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

442

3755

0.69

12.36

1.1

5.8

3.7

u/ml

1.01

197

1465

(3013139) Helicobacter pylori Ag [Presence] in Stool

3551

18474

1.15

12.32

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

282

1031

1.62

12.25

9.4

4.3

3456.1

2637.1

mg/l

0.21

207

719

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

118

326

2.14

12.22

1.2

1.5

557451.7

166304.2

nmol/l

0.80

270

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1144

5374

1.27

12.06

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

739

3274

1.34

12.06

1.5

1.6

60.2

56.2

1.77

451

2081

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

311

1171

1.57

11.99

1.5

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

333

1274

1.55

11.98

1.6

6.6

5.3

mmol/24h

0.75

109

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

311

1172

1.57

11.94

1.5

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1007

4667

1.28

11.86

1.5

1.4

109.1

112.2

u/ml

0.49

241

1076

(3017732) Neutrophils [#/volume] in Blood

3698

19342

1.14

11.86

3.5

2.7

4.5

4.0

e9/l

30.06

2805

15191

(3025468) Yersinia sp identified in Specimen by Organism specific culture

752

3353

1.33

11.76

1.4

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

392

1562

1.49

11.70

1.5

1.6

8.4

5.7

u/l

1.49

184

768

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

757

3385

1.33

11.62

1.4

—

(40768443) Skin Pathology biopsy report

2351

11927

1.17

11.43

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

873

3997

1.30

11.32

3.2

2.9

—

(3001556) Androgen free Index in Serum or Plasma

207

2.40

11.32

1.3

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

589

4704

0.74

11.31

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

750

3363

1.32

11.31

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

749

3359

1.32

11.28

1.4

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1045

4905

1.27

11.14

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

590

4696

0.74

11.08

1.1

—

(3051651) Icteric interference index of Serum or Plasma

367

1460

1.49

11.07

4.5

3.6

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

237

852

1.65

11.06

2.3

2.2

1.0

ug/l

0.09

217

805

(3010144) Erythrocytes [#/volume] in Synovial fluid

562

2420

1.38

11.04

1.4

115821.7

110507.0

e6/l

0.06

372

1665

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

790

6036

0.77

11.01

1.8

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

1596

7856

1.21

10.94

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1593

7842

1.21

10.91

1.2

—

(3035880) pH of Pleural fluid

311

1202

1.53

10.75

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3891

20548

1.13

10.74

2.6

2.1

9.6

13.2

nmol/l

157.80

3401

18460

(3021788) Differential panel - Synovial fluid

1026

4829

1.26

10.71

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

751

3399

1.31

10.63

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

103

286

2.13

10.61

4.8

4.7

—

(40768806) Pleura Pathology biopsy report

551

2383

1.37

10.56

1.5

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

129

2.75

10.56

2.9

2.0

14.9

17.3

0.22

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1576

7777

1.20

10.54

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

124

371

1.98

10.52

2.2

1.6

56.4

57.9

pmol/l

0.03

103

314

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1159

8426

0.81

10.51

1.3

185.2

223.7

miu/ml

3.11

424

3997

(3023323) Follitropin [Units/volume] in Serum or Plasma

2166

14877

0.86

10.42

1.4

1.3

22.5

31.5

iu/l

41.73

1839

13016

(43055442) Apixaban [Mass/volume] in Serum or Plasma

261

2.18

10.42

1.6

1.5

118.5

112.3

ug/l

0.20

209

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

216

772

1.66

10.34

1.4

64.6

60.5

0.92

183

629

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

451

3693

0.72

10.24

1.5

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

276

2468

0.66

10.22

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

326

1292

1.50

10.07

1.1

29.7

23.1

u/l

0.92

259

997

(4211845)

332

1323

1.49

9.99

3.3

2.8

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

325

1291

1.49

9.94

1.1

90.5

82.7

u/l

0.76

273

1031

(40768793) Breast Pathology biopsy report

883

6570

0.79

9.93

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

266

1013

1.56

9.87

26.1

29.0

124.8

118.2

ug/l

0.79

204

863

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

270

1033

1.55

9.82

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

264

2.13

9.80

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

157

1573

0.59

9.65

1.0

0.5

0.8

u/ml

0.20

189

(3011335) Digoxin [Mass/volume] in Serum or Plasma

157

2.49

9.63

2.4

2.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

677

3066

1.31

9.60

1.9

22.0

24.4

ug/l

0.46

660

3007

(3006462) Nitrate [Presence] in Urine

306

1211

1.50

9.55

3.3

2.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3682

19519

1.12

9.55

1.4

—

(3012898) Urea [Moles/volume] in Urine

202

2.29

9.51

1.5

1.6

185.4

183.5

mmol/l

0.04

183

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

120

2.71

9.47

1.3

1.4

61.2

1547.2

u/l

1.34

105

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

199

2.29

9.44

1.3

1.2

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

3.29

9.43

1.0

1.1

170.5

218.8

pmol/l

0.39

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

121

375

1.91

9.35

7.3

7.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

272

2388

0.67

9.24

1.4

1.3

124.6

117.6

pmol/l

0.03

141

745

(3020717) Zinc [Moles/volume] in Serum or Plasma

312

1249

1.48

9.23

1.5

19.5

27.4

umol/l

5.37

296

1191

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

122

381

1.90

9.22

1.1

4.2

7.9

pmol/l

0.37

(3045424) Erythrocytes [Presence] in Urine

953

4530

1.25

9.21

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1613

8081

1.19

9.19

1.4

1.7

0.3

0.2

g/l

31.31

1535

7656

(4198724)

274

1069

1.52

9.17

1.8

2.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

218

2.20

9.07

1.1

—

(4024509)

540

2389

1.34

9.04

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

8829

48948

1.08

8.98

1.3

38.1

36.4

iu/ml

0.19

2610

15757

(3025315) Body weight

152

2.45

8.96

4.9

4.1

—

(3008898) HLA-B27 [Presence]

1406

9872

0.84

8.91

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2007

10263

1.16

8.90

1.6

1.7

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

390

1641

1.41

8.89

1.3

12.0

14.6

u/l

2.12

356

1519

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

121

383

1.87

8.81

1.0

77.1

82.8

ug/l

0.78

102

306

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

546

2431

1.33

8.77

3.4

3.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

544

2421

1.33

8.77

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

437

1882

1.38

8.70

3.0

2.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

403

1714

1.39

8.65

1.5

1.4

14.3

11.8

u/l

6.94

388

1661

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

495

2178

1.35

8.62

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

495

2178

1.35

8.62

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

495

2178

1.35

8.62

1.6

1.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

357

1488

1.42

8.60

1.2

28.0

22.9

u/l

0.93

307

1270

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1549

10751

0.85

8.57

2.1

1.6

4.9

3.3

mg/l

7.82

1325

7371

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1650

8342

1.18

8.47

1.4

1.7

1.3

1.2

g/l

66.84

1571

7943

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

241

933

1.53

8.40

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

365

1535

1.41

8.38

1.2

97.2

85.0

u/l

1.37

315

1342

(3027135) IgG subclass 1 [Mass/volume] in Serum

608

2768

1.30

8.37

1.4

6.5

6.8

g/l

1.30

408

1934

(37019676) Renin [Units/volume] in Plasma --supine

3.86

8.23

1.0

1.1

52.8

70.6

mu/l

0.16

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

8304

46084

1.08

8.17

1.3

10.2

12.1

u/ml

1.58

3161

18297

(3024139) IgG subclass 3 [Mass/volume] in Serum

605

2766

1.30

8.09

1.4

0.4

g/l

0.08

404

1944

(3028192) IgG subclass 2 [Mass/volume] in Serum

605

2768

1.30

8.05

1.4

2.9

3.0

g/l

0.64

407

1930

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

290

1.96

8.05

1.2

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

258

2.02

8.01

1.2

1.3

415.2

85.1

u/l

0.49

187

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

118

2.56

7.93

1.5

1.4

23.9

22.6

mmol/l

1.08

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2744

18195

0.89

7.91

1.3

40.0

50.6

au/ml

1.54

820

(3024263) Appearance of Synovial fluid

323

1344

1.42

7.90

1.6

1.8

—

(4062490)

604

2777

1.29

7.76

1.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.32

7.71

1.8

2.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

364

1554

1.39

7.71

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

731

5380

0.80

7.58

1.1

1.3

1.4

u/ml

0.19

305

2072

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3026

19894

0.89

7.52

2.3

2.4

23.6

24.4

au/ml

0.11

1294

(3041806) Other cells [#/volume] in Blood by Manual count

657

0.45

7.50

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

274

1117

1.45

7.50

11.9

8.3

—

(36660697) Celiac disease serology panel - Serum

3853

20758

1.11

7.47

1.2

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

180

671

1.59

7.45

1.3

3.2

3.6

mmol/l

0.95

160

618

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

584

2691

1.29

7.41

1.6

1.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

161

1491

0.64

7.22

1.4

1.5

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.88

7.17

1.3

1.4

504.9

517.7

nmol/l

0.04

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

205

2.08

7.12

1.1

1.2

42.5

49.8

mg/l

1.11

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

226

899

1.49

7.03

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

175

658

1.58

7.02

1.4

2.1

2.8

0.56

152

552

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

110

366

1.78

6.95

1.3

1.4

151.2

332.2

ng/l

0.35

233

(3013005) Retinol [Moles/volume] in Serum or Plasma

250

1018

1.46

6.93

1.7

1.6

2.0

umol/l

0.23

238

951

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

538

2478

1.29

6.89

1.7

1.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

155

569

1.61

6.87

1.1

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

662

4868

0.80

6.86

1.1

4.0

4.5

u/ml

0.37

313

2415

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

395

1744

1.34

6.84

1.7

—

(46235168) Fasting glucose [Moles/volume] in Blood

274

1.90

6.84

2.1

1.1

8.4

5.7

mmol/l

9.91

(3048929) Epstein Barr virus Ab [Presence] in Serum

1464

7469

1.16

6.80

1.2

—

(3035082) Kappa light chains [Mass/volume] in Urine

3.40

6.76

1.1

0.0

0.3

g/l

0.44

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

190

2.09

6.72

1.3

1.6

ml/s/173m2

0.34

127

(3033923) Metanephrine [Moles/time] in 24 hour Urine

145

527

1.63

6.70

1.1

1.4

3.2

umol/24h

0.32

276

(3036489) Thrombin time

1944

10135

1.14

6.68

2.3

2.0

21.7

21.3

1.54

1718

8754

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

252

1.93

6.63

1.1

1.2

—

1.5

mmol/l

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.84

6.63

1.1

1.2

1902.0

4345.2

ng/l

0.93

(3008401) Mugwort IgE Ab [Units/volume] in Serum

629

4631

0.80

6.61

1.1

0.9

1.0

u/ml

0.32

248

1861

(3035947) Staphylolysin Ab [Units/volume] in Serum

296

1255

1.40

6.61

1.2

1.1

3.5

4.2

iu/ml

0.36

(3000285) Sodium [Moles/volume] in Blood

278

1.87

6.57

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

312

1.82

6.57

1.2

1.1

1.7

mmol/l

0.62

200

(40761995) Spermatozoa Progressive [#/volume] in Semen

497

0.42

6.49

2.1

3.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

196

1703

0.68

6.47

1.0

0.6

1.3

u/ml

1.31

366

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

496

0.42

6.46

4.2

6.5

—

(3015183) Erythrocyte sedimentation rate

180

1581

0.67

6.31

1.3

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

156

587

1.57

6.29

1.4

23.9

22.2

0.31

145

527

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1625

8407

1.15

6.28

2.5

2.1

90.2

92.5

3.38

1522

7787

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

221

1.96

6.19

1.2

1.1

20.6

20.9

u/l

0.04

150

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

553

4097

0.80

6.19

1.1

2.5

2.9

u/ml

0.42

221

2078

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

677

3252

1.23

6.13

1.1

—

(4281824)

609

2897

1.25

6.03

1.2

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

114

402

1.68

5.96

1.2

1.4

1.9

mmol/l

4.16

242

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

553

2607

1.26

5.94

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.62

5.80

1.1

222.8

254.0

nmol/l

0.64

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

674

3259

1.23

5.77

2.2

2.0

23.8

27.4

mg/l

0.86

194

840

(21494434) Karyotype in Bone marrow

460

2130

1.28

5.74

1.1

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

883

4389

1.19

5.69

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

281

2245

0.74

5.68

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

526

2479

1.26

5.68

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

579

2759

1.24

5.68

2.4

2.5

—

(3006969) Lambda light chains [Mass/volume] in Urine

3.23

5.62

1.0

1.1

0.0

0.1

g/l

0.52

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

157

609

1.53

5.60

1.3

280.3

332.6

ug/l

0.11

329

(3032057) Clostridioides difficile [Presence] in Stool

139

526

1.57

5.54

1.8

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

185

1.98

5.52

1.2

137.3

94.2

ug/l

1.13

107

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

344

1.70

5.50

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

232

1897

0.72

5.48

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

277

1203

1.36

5.45

3.5

3.8

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

138

524

1.56

5.43

1.4

22.7

23.9

0.20

115

426

(40757373) Influenza virus identified in Isolate

127

474

1.59

5.37

1.7

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

267

1157

1.37

5.33

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

267

1157

1.37

5.33

1.5

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

334

1.70

5.32

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

292

1284

1.35

5.32

1.5

3.3

3.6

0.22

275

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

265

1148

1.37

5.31

1.5

2128690.6

2296938.0

iu/ml

0.06

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

135

513

1.56

5.30

3.1

6.4

65.1

72.2

2.06

110

396

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

7938

49430

0.94

5.24

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

208

1712

0.72

5.15

1.0

0.6

2.4

u/ml

0.82

439

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

238

1021

1.38

5.08

1.6

28.2

30.2

umol/l

2.31

233

981

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1481

7737

1.14

5.04

2.9

2.4

208.2

183.0

18.81

1409

7295

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

138

1215

0.67

5.01

1.8

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

224

954

1.39

5.00

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

448

2109

1.26

4.96

1.3

1.2

—

(4094501)

1467

7673

1.13

4.91

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

158

633

1.48

4.90

1.2

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

198

829

1.41

4.88

1.3

1.5

613.2

688.6

mu/l

0.21

181

794

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

353

1.64

4.82

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

217

1.83

4.76

1.0

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

212

903

1.39

4.75

2.1

1.9

196.2

162.9

3.43

200

851

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

631

0.56

4.70

1.1

62.3

63.2

u/ml

0.03

612

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

329

1.66

4.67

1.4

9.1

13.0

0.79

167

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

4.53

4.65

1.2

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

180

749

1.42

4.62

1.6

9.8

8.8

ug/l

2.08

180

749

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

200

848

1.40

4.62

1.3

1.5

71.5

72.9

0.55

183

813

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.38

4.59

1.1

0.9

1.5

u/field

0.76

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

323

1475

1.30

4.59

1.9

1.7

2.4

u/field

0.02

243

1050

(3042517) Benzodiazepines panel - Urine

268

1.72

4.58

3.6

2.8

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

255

1.74

4.57

2.1

2.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

7473

46432

0.95

4.55

1.8

—

(3048879) Bone marrow aspiration report

174

722

1.43

4.54

1.4

2.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

302

1369

1.31

4.54

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.35

4.49

13.8

11.4

—

(3011544) Albumin [Mass/volume] in Pleural fluid

200

1.84

4.48

1.2

1.1

16.8

17.9

g/l

0.52

178

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

401

1890

1.26

4.44

1.4

14.0

11.8

umol/l

6.89

370

1820

(3052592) Norovirus Ag [Presence] in Stool

128

503

1.51

4.41

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

455

0.51

4.36

1.6

1.9

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

140

1.99

4.29

1.1

1.2

1.3

u/field

0.37

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1455

9632

0.89

4.25

1.4

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

117

459

1.51

4.09

1.5

1.6

—

(3026480) Teichoate Ab [Titer] in Serum

211

1.77

4.08

1.0

2.3

3.2

titre

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

183

784

1.38

4.04

1.4

59.5

54.0

1.15

155

670

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

366

1.57

4.04

2.2

3.4

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

248

1.70

3.99

1.3

1.4

70.6

71.3

0.06

201

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

193

1536

0.74

3.96

1.4

1.3

—

(3002619) Bacteria identified in Specimen by Culture

126

508

1.47

3.89

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

128

518

1.46

3.88

1.2

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

158

1291

0.72

3.86

1.6

1.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

207

1.74

3.81

1.7

1.6

45.3

45.2

umol/l

0.01

207

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

393

1886

1.23

3.78

1.8

1.7

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

156

660

1.40

3.74

1.3

37.8

39.3

0.17

464

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1342

7115

1.12

3.70

1.2

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1132

5942

1.13

3.70

1.3

1.2

4.4

3.5

mmol/l

67.08

1055

5580

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

691

4751

0.86

3.65

3.3

3.6

33.5

38.5

u/ml

0.37

659

4587

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

187

819

1.35

3.65

1.9

2.0

—

(44786800) Granulocytes/100 leukocytes in Body fluid

278

1.62

3.63

1.4

1.3

19.2

27.5

1.38

218

(40765089) Chromosome analysis panel - Blood by G-banded

658

0.63

3.60

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

301

1414

1.26

3.53

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

147

623

1.40

3.52

1.3

1.5

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

4.07

3.52

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

118

1.96

3.48

1.1

1.2

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

102

405

1.49

3.44

3.4

2.7

1172.2

2100.2

u/l

0.81

361

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

306

1.57

3.42

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

192

1.73

3.41

1.5

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

377

1.51

3.41

1.7

1.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

641

4406

0.86

3.41

1.1

13.4

11.3

au/ml

0.18

292

(3003694) ABO and Rh group [Type] in Blood

13159

75611

1.04

3.40

1.4

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

145

1.84

3.36

1.6

1.3

19.4

16.5

pmol/l

0.25

123

(3027570) Oxalate [Moles/time] in 24 hour Urine

158

1.80

3.35

1.9

1.3

322.0

337.6

umol/24h

0.19

158

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

113

461

1.45

3.34

4.1

5.3

45.5

59.4

u/l

0.77

182

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

418

2050

1.21

3.31

1.3

2.3

2.0

mmol/l

4.36

380

1904

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

102

409

1.48

3.30

1.2

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

625

4283

0.86

3.22

1.6

1.4

0.4

nmol/l

0.18

474

3270

(40763791) Oxygen content in Venous blood by calculation

2.35

3.19

7.1

7.0

11.9

12.1

ml/dl

0.09

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.35

3.19

1.1

—

mmol/l

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1268

6768

1.11

3.16

1.3

607.2

530.8

mg/l

1.76

1200

6462

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1090

5771

1.12

3.15

1.2

13.7

12.7

u/ml

0.05

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

194

877

1.31

3.12

1.3

1.2

110.1

111.1

0.18

176

789

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

265

1247

1.26

3.12

2.1

1.8

165.5

141.3

4.55

246

1174

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.37

3.11

1.4

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

230

1.62

3.09

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

171

761

1.33

3.07

1.2

39.7

40.3

g/l

0.18

101

399

(3035933) Granulocytes/100 leukocytes in Blood

772

0.69

3.02

2.3

1.8

—

(4035726)

4294

24113

1.06

2.98

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

118

1.86

2.89

5.7

4.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

287

1.53

2.85

2.1

2.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.37

2.85

3.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

144

633

1.35

2.84

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

206

953

1.28

2.83

1.3

1.2

0.3

g/l

2.68

165

757

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1241

6665

1.10

2.80

1.7

1.9

11.3

11.2

iu/l

0.00

418

2503

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

860

4527

1.13

2.79

1.4

1.3

22.3

30.8

u/l

13.88

693

3724

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.00

2.79

2.9

3.6

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

411

2052

1.19

2.76

1.2

5.9

8.6

u/ml

0.34

155

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

178

1.66

2.74

1.1

1.2

19.1

22.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

127

551

1.36

2.74

1.3

1.1

84.3

89.4

0.59

146

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

159

714

1.32

2.73

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

147

1.73

2.72

1.0

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

126

547

1.36

2.71

1.2

1.1

79.3

75.9

0.29

136

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

126

548

1.36

2.68

1.1

1.2

12.6

40.1

mg/l

0.74

401

(3005322) IgE [Units/volume] in Serum or Plasma

3141

17539

1.06

2.67

1.3

264.4

223.0

u/ml

1.18

2899

16278

(40758292) HTLV I+II Ab panel - Serum

491

0.64

2.66

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

221

1.58

2.66

1.1

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

2.76

2.66

1.5

1.2

134.6

171.8

nmol/l

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

198

1.61

2.65

1.2

1.1

11.9

8.7

mg/l

0.81

184

(3040893) Potassium [Moles/volume] in Capillary blood

2.22

2.62

2.0

1.6

4.3

mmol/l

0.11

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

340

1678

1.20

2.62

1.0

275.2

347.2

ng/l

2.18

240

1203

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

142

632

1.33

2.61

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

436

2200

1.17

2.61

1.2

43.3

52.9

u/ml

—

110

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

204

1.60

2.59

1.3

14.6

14.4

pmol/l

0.02

173

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1111

5967

1.10

2.54

1.5

1.4

943.8

2276.9

e6/l

1.26

892

4852

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

341

1689

1.20

2.54

1.0

736.4

741.2

ng/l

0.07

230

1168

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

425

2147

1.17

2.52

1.2

71.1

69.7

u/ml

0.03

108

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

143

641

1.32

2.52

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

191

890

1.27

2.52

2.1

1.6

59053.3

17105.8

u/ml

0.32

119

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

341

1693

1.19

2.48

1.0

33.9

43.3

ng/l

4.11

233

1194

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1109

5964

1.10

2.48

1.4

25.7

34.2

e6/l

0.46

834

4621

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

133

592

1.33

2.47

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

141

633

1.32

2.47

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

279

1360

1.22

2.47

1.8

1.9

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.54

2.46

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

425

2154

1.17

2.44

1.2

40.6

45.3

u/ml

0.13

169

(3018291) Platelet Ab [Presence] in Serum

2.43

2.42

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

278

1358

1.21

2.41

1.8

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

278

1358

1.21

2.41

1.8

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

278

1358

1.21

2.41

1.8

1.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

334

1662

1.19

2.39

1.5

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

200

1472

0.80

2.39

6.3

6.1

1093.4

3431.4

u/ml

0.51

299

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

177

1.61

2.35

4.5

4.9

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

345

1.42

2.34

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

548

2841

1.14

2.33

1.1

—

(3002256) Pathology report gross observation

6424

36674

1.04

2.31

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

621

0.70

2.30

2.5

2.8

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

146

1.66

2.29

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

795

5233

0.90

2.29

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.29

1.1

75.9

96.3

nmol/24h

0.84

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

197

1.56

2.29

1.3

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1257

8092

0.92

2.28

1.4

1.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

379

0.62

2.28

1.0

1.1

1.7

0.7

u/ml

0.26

266

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

2.00

2.27

12.8

12.9

204.0

544.7

e6/l

0.68

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

308

1.44

2.27

1.4

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3311

18632

1.05

2.21

1.2

123.2

144.4

iu/ml

2.29

1157

7211

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

257

1261

1.21

2.17

1.2

1.1

—

(3001729) Color of Synovial fluid

195

1.55

2.17

1.5

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

192

914

1.24

2.17

1.6

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

374

0.63

2.17

1.7

2.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

346

1.40

2.16

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

153

1142

0.79

2.12

1.7

1.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

279

1.44

2.09

1.1

—

(3000219) Insulin receptor Ab [Presence] in Serum

5.92

2.07

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

137

1.64

2.06

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.77

2.04

1.1

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

295

0.60

2.03

2.4

2.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

166

1.57

2.01

1.0

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

305

2114

0.85

1.98

2.3

2.6

729.7

712.7

e6/l

0.09

119

873

(3027874) Urate [Moles/volume] in Urine

1.89

1.98

1.0

1.1

1.6

9.7

mmol/l

0.51

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

148

1.60

1.98

1.0

1.1

50.8

92.5

u/l

0.47

120

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1569

8662

1.07

1.97

1.6

1.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

339

1.38

1.93

1.1

—

(3016228) CD19 cells/100 cells in Blood

219

1074

1.21

1.91

1.9

2.1

9.0

8.3

0.34

209

1054

(3009677) Dengue virus Ab [Presence] in Serum

111

0.43

1.89

1.1

1.2

—

(3051339) Copper [Moles/volume] in Blood

127

1.63

1.88

1.2

1.1

18.0

16.4

umol/l

1.19

112

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

139

651

1.26

1.86

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

139

651

1.26

1.86

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

139

651

1.26

1.86

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

139

651

1.26

1.86

1.0

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.33

1.85

7.8

8.6

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

264

1322

1.18

1.85

1.3

1.2

61.6

61.4

0.01

149

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

105

1.69

1.84

7.3

9.0

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

119

1.64

1.82

1.5

1.6

0.0

0.3

u/l

1.57

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

110

1.67

1.81

1.2

1.1

323.8

446.7

u/l

0.41

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

195

1.49

1.80

1.1

5.3

19.4

iu/ml

2.30

(3018133) Calcium [Moles/volume] in Urine

359

1.35

1.79

1.5

1.7

2.6

2.7

mmol/l

0.18

320

(3011897) Casein IgE Ab [Units/volume] in Serum

399

0.68

1.79

1.1

1.2

0.0

6.4

u/ml

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

481

3201

0.89

1.77

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

201

1426

0.83

1.76

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

144

683

1.25

1.75

2.1

1.7

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

265

1.41

1.75

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

285

1.39

1.75

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2244

12589

1.06

1.75

1.1

194.8

212.3

titre

0.09

303

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

480

0.71

1.74

1.1

—

(3000492) Spirometry study

4819

27531

1.04

1.73

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

388

0.69

1.71

1.3

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2012

11261

1.06

1.71

1.2

1.3

0.8

0.9

u/ml

0.27

182

988

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

131

1.58

1.69

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

123

576

1.26

1.68

1.1

—

(3028433) Virus identified in Specimen by Culture

178

869

1.21

1.67

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

1030

5641

1.08

1.66

1.4

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.87

1.63

1.2

—

(3003338) MCHC [Mass/volume]

40577

238535

1.02

1.63

24.6

15.8

331.2

332.8

g/l

193.05

40265

236716

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1172

7445

0.93

1.63

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

120

564

1.26

1.61

1.2

—

(3017509) Phencyclidine [Presence] in Urine

285

1.37

1.60

2.0

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

939

6010

0.92

1.59

1.2

38.5

43.1

u/ml

0.35

630

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

150

724

1.23

1.59

1.3

142.7

126.1

nmol/l

0.42

106

535

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

302

2052

0.87

1.58

1.3

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

204

1017

1.19

1.56

1.1

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

372

1944

1.13

1.53

1.7

1.5

74.2

69.0

umol/l

0.79

166

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

1.79

1.52

4.5

6.4

1.1

1.4

mg/l

0.44

(3047007) Chlamydophila sp Ab [Presence] in Serum

636

4128

0.91

1.51

1.2

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

107

1.60

1.51

2.6

2.5

1.7

1.9

mg/l

0.22

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

214

0.61

1.50

1.0

0.7

1.3

u/ml

0.18

152

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

125

910

0.81

1.48

2.9

3.2

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.70

1.48

1.0

1.1

6.7

4.4

mmol/l

1.47

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

138

994

0.82

1.48

1.9

7.3

9.5

mg/l

4.70

108

797

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

1.84

1.47

1.2

1.0

0.9

1.4

u/field

0.98

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

223

1128

1.17

1.46

1.8

2.1

—

(3014891) Appearance of Pleural fluid

311

1.33

1.45

1.7

1.6

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

113

1.57

1.45

1.0

0.0

0.1

u/ml

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

152

0.54

1.44

1.1

—

(3022475) Manganese [Moles/volume] in Blood

189

0.59

1.43

1.2

1.3

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

128

1.53

1.41

1.0

0.0

0.1

u/ml

—

(3027944) Amphetamines [Presence] in Urine

1532

9593

0.94

1.41

2.3

2.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.65

1.41

1.1

—

(4038314)

143

0.54

1.41

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.32

1.40

5.3

4.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

246

1260

1.16

1.39

1.2

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

214

1085

1.17

1.38

2.0

2.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

268

1.35

1.37

1.0

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

173

1.44

1.36

1.2

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

209

1059

1.17

1.36

1.9

2.0

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

321

0.70

1.35

1.9

1.7

1.6

1.7

mg/l

0.20

266

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

211

1071

1.17

1.35

2.0

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

211

1071

1.17

1.35

2.0

2.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

361

1902

1.12

1.34

1.9

2.1

—

(3045142) Bone marrow Pathology biopsy report

526

2829

1.10

1.34

1.2

1.3

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.73

1.34

1.0

1.1

16.2

16.0

umol/l

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.73

1.34

1.0

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

117

846

0.82

1.33

1.0

—

(4212803)

219

1.38

1.33

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

297

1991

0.88

1.32

1.3

1.5

g/l

0.00

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

363

1.29

1.32

1.4

58.4

50.5

0.63

191

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.73

1.31

1.2

1.7

84.0

138.3

ug/l

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

268

1388

1.14

1.31

1.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.61

1.31

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

346

0.72

1.30

1.4

—

(3027008) Opiates [Presence] in Urine

1565

9761

0.95

1.28

2.5

2.0

—

(3021374) Sirolimus [Mass/volume] in Blood

2.37

1.28

8.5

9.9

7.8

6.7

ug/l

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

2.37

1.28

1.0

—

(3028300) Cannabinoids [Presence] in Urine

1569

9784

0.95

1.28

2.5

2.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

471

1.24

1.26

1.1

1.4

15.6

156.6

titre

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.77

1.26

1.1

1.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1058

5873

1.07

1.26

1.2

1.3

5.2

6.3

u/ml

0.15

477

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

431

2819

0.90

1.26

3.6

3.8

45.4

49.8

u/ml

0.29

425

2788

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

108

1.53

1.25

1.3

222.0

170.6

ug/g

0.50

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

642

4122

0.92

1.25

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.63

1.24

1.4

1.2

—

(3011436) Histone Ab [Units/volume] in Serum

118

574

1.22

1.23

1.1

—

39.4

u/ml

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

255

1325

1.14

1.21

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

347

1.28

1.21

13.2

7.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

673

0.81

1.20

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

140

983

0.84

1.20

1.1

—

(4015189)

142

706

1.19

1.8

2.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1235

6904

1.06

1.19

1.3

—

(3033942) Copper [Moles/time] in 24 hour Urine

100

1.54

1.19

1.0

1.1

0.3

0.5

umol/24h

0.28

(3021367) Citalopram [Moles/volume] in Serum or Plasma

1.84

1.18

1.3

1.4

102.8

164.7

nmol/l

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

105

1.52

1.18

1.1

1.3

1.0

1.2

u/field

0.60

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

129

909

0.84

1.16

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.54

1.16

1.2

0.1

g/l

0.57

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

200

1.36

1.15

2.1

3.1

26.9

383.5

pmol/l

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.78

1.14

1.1

1.5

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

170

1.39

1.14

1.6

1.7

0.6

0.7

0.22

134

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

164

830

1.17

1.13

1.3

1.2

21.9

21.5

0.02

140

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

294

1551

1.12

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

334

2197

0.90

1.12

1.1

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

206

1.35

1.12

1.9

2.7

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

363

0.75

1.12

1.1

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

107

764

0.83

1.12

1.2

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.80

1.12

1.8

1.4

2.9

2.1

mmol/24h

0.51

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

334

2196

0.90

1.11

1.1

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

122

603

1.20

1.11

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

281

1480

1.12

1.11

1.5

8.8

7.8

ug/l

0.44

250

1339

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

117

827

0.84

1.10

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

335

2198

0.90

1.08

1.1

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.60

1.08

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.53

1.08

1.2

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

752

4764

0.93

1.08

1.3

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

107

760

0.83

1.07

1.5

2.1

1068.1

353.1

e6/l

0.57

396

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

123

0.58

1.07

1.0

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

626

3437

1.08

1.06

1.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

180

924

1.15

1.06

1.1

1.2

0.1

0.6

g/l

—

(3011325) HIV 1+2 Ab [Presence] in Serum

118

1.45

1.05

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

1564

9689

0.95

1.04

2.5

2.1

—

(40765096) Chromosome analysis panel by Banding

144

728

1.17

1.03

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

184

948

1.15

1.03

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

541

2958

1.08

1.03

1.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

165

0.65

1.02

1.2

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

115

807

0.84

1.02

1.7

1.6

228.7

115.3

au/ml

1.28

(1175426) CD3 cells/100 lymphocytes in Blood

383

2064

1.10

1.01

1.8

2.1

72.9

72.8

0.03

366

1983

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

143

0.62

1.01

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.82

1.00

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

648

3575

1.07

0.99

2.0

2.2

5.0

8.3

titre

0.52

121

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

334

2178

0.91

0.98

1.1

1.2

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

205

0.69

0.97

2.2

2.1

2.2

3.1

mg/l

1.48

197

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

563

3092

1.08

0.97

1.2

1.1

2.2

2.0

iu/ml

0.12

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.54

0.96

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

334

2173

0.91

0.95

1.1

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

141

1.39

0.95

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1492

8447

1.05

0.95

1.7

1.6

0.2

6.7

iu/ml

2.26

334

1768

(40768804) Tissue Pathology biopsy report

19271

115203

0.99

0.94

2.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

130

659

1.17

0.93

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1444

8932

0.96

0.93

2.5

2.2

4133.5

5316.2

u/l

1.17

569

3446

(3044336) Cobalt [Moles/volume] in Urine

0.48

0.93

3.4

2.5

33.6

26.9

nmol/l

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

335

2175

0.91

0.92

1.1

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

351

1.23

0.92

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

133

677

1.16

0.91

1.1

1.8

1.6

u/ml

0.08

373

(3006598) pH of Arterial cord blood

1.97

0.91

1.4

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.71

0.91

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

242

1595

0.90

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.54

0.88

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

226

1.28

0.88

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

632

3504

1.07

0.87

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

156

807

1.14

0.87

1.1

1.3

—

(3045462) Protein/Creatinine [Ratio] in Urine

164

1.34

0.87

4.2

3.0

61.8

28.6

g/mol

0.82

148

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

195

1.31

0.87

1.1

8.5

10.2

u/l

0.32

195

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

342

1852

1.09

0.86

1.2

1.3

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

247

0.74

0.86

1.0

0.5

0.1

u/ml

0.40

153

(3036005) Urine sediment comments by Light microscopy Narrative

1.82

0.85

1.0

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

344

1.22

0.85

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

212

0.73

0.84

1.0

0.1

0.4

u/ml

0.79

152

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

359

0.79

0.84

1.1

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

1.97

0.84

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

477

3035

0.93

0.83

1.5

1.4

5.2

3.6

ug/l

3.76

421

2576

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

205

0.72

0.83

1.1

1.3

—

(3036180) Methadone [Presence] in Urine

1.62

0.83

3.0

2.7

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

150

1.34

0.83

1.7

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

378

0.80

0.83

1.8

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

289

1876

0.91

0.82

2.2

2.7

0.2

e9/l

0.13

259

1622

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

154

1034

0.88

0.81

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

766

4286

1.06

0.81

1.3

1.2

4.1

3.8

u/ml

0.20

338

1883

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

1.64

0.80

1.0

11879.0

11892.3

ng/l

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

343

1867

1.09

0.79

1.2

1.3

—

(3028468) Fragments [Presence] in Blood by Light microscopy

1.87

0.79

3.5

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

278

1.23

0.78

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

384

2455

0.93

0.78

2.0

2.2

37.9

40.3

0.49

330

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

2.28

0.78

1.2

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

2.28

0.78

1.2

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.56

0.77

5.9

5.5

0.4

0.2

mmol/l

1.19

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

333

1.21

0.76

2.9

3.1

37.6

42.5

umol/l

1.08

284

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

372

2037

1.08

0.75

1.8

2.1

14.1

14.9

0.53

158

932

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

1.50

0.75

1.4

1.6

321.2

235.6

nmol/l

0.24

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

300

1628

1.09

0.75

1.6

1.4

6.8

5.8

u/l

0.65

251

1371

(3013862) HLA-DP [Type]

118

0.65

0.75

1.0

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

146

0.69

0.75

1.0

1.1

28.6

24.3

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

146

0.69

0.75

1.0

1.1

36.1

19.7

u/ml

—

(44813793)

356

1947

1.08

0.75

1.1

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.46

0.75

1.0

0.1

0.0

u/ml

0.41

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

147

982

0.89

0.74

2.8

3.0

8.0

7.9

mg/l

0.06

106

789

(3005082) Progesterone [Moles/volume] in Serum or Plasma

217

1161

1.11

0.74

1.6

1.3

26.8

31.1

nmol/l

1.48

192

1047

(3014148) Varicella zoster virus Ab [Titer] in Serum

595

3318

1.06

0.73

1.1

1.2

—

(40760410) HLA-B [Type] by High resolution

117

0.66

0.73

1.0

—

(40760409) HLA-A [Type] by High resolution

117

0.66

0.73

1.0

—

(46236302) HLA-C [Type] by High resolution typing

117

0.66

0.73

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

159

1.30

0.73

1.7

1.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.80

0.73

2.3

3.6

—

(4133840)

124

836

0.88

0.72

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.39

0.71

1.6

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.44

0.71

1.1

1.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

303

1942

0.92

0.69

2.1

2.6

530.6

531.7

e6/l

0.01

258

1632

(40763590) HLA-DQ beta [Type]

115

0.67

0.68

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

170

903

1.11

0.68

1.2

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

147

775

1.12

0.67

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

243

1316

1.09

0.67

1.1

6.9

7.0

u/ml

0.01

218

(3023511) Choriogonadotropin [Units/volume] in Urine

704

4378

0.95

0.64

1.4

1.3

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.64

0.63

1.1

—

(3034707) Cochineal extract IgE Ab [Units/volume] in Serum

0.00

0.63

0.0

1.1

—

0.9

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

351

0.83

0.63

7.7

7.3

0.4

0.3

umol/l

0.60

316

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

137

907

0.89

0.62

2.3

2.5

160.5

164.0

au/ml

0.03

119

(3004716) Salmonella sp identified in Stool by Organism specific culture

2380

13729

1.03

0.61

1.3

1.4

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.61

0.0

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

170

910

1.11

0.61

1.1

113.4

107.8

0.97

161

820

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

146

0.73

0.61

1.0

0.0

1.0

u/ml

0.87

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

125

0.71

0.59

1.1

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.53

0.59

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

135

890

0.90

0.58

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

220

1416

0.92

0.58

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

373

2070

1.07

0.58

1.3

1.4

1.3

u/ml

0.13

180

944

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

273

1.19

0.58

1.0

1.1

2.4

2.9

umol/24h

0.17

273

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

563

0.87

0.57

3.5

2.8

70.3

103.2

ng/l

1.08

219

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

108

567

1.13

0.56

1.4

1.2

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.52

0.55

1.1

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

260

1657

0.93

0.55

1.7

1.5

10.2

7.6

mmol/l

16.65

158

1005

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.61

0.55

1.2

3.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

211

1149

1.09

0.55

1.1

1565.8

1500.7

miu/ml

0.37

211

1149

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

324

1.17

0.55

1.2

1.3

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

129

0.73

0.53

1.0

5.5

4.5

u/ml

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

135

721

1.11

0.53

1.9

2.0

32.1

39.2

u/l

0.24

119

650

(3008536) Aspergillus sp Ab [Presence] in Serum

103

542

1.12

0.52

2.3

2.1

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.43

0.52

1.1

1.0

0.0

0.2

u/ml

—

(40762887) Creatinine [Moles/volume] in Blood

1.43

0.52

1.2

—

(3034614) HLA Ag [Interpretation]

0.65

0.50

1.0

1.2

—

(40759632) Porphyrins [Mass/mass] in Stool

1.59

0.50

1.0

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1287

7390

1.03

0.50

2.6

2.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

198

1083

1.08

0.49

2.5

2.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.42

0.48

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

162

879

1.09

0.48

1.1

90.0

91.2

0.10

424

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

384

1.14

0.48

2.3

2.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

524

1.12

0.47

1.5

1.9

2.1

3.8

ug/l

0.93

314

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.48

0.47

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

338

2118

0.94

0.47

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

166

904

1.09

0.46

1.1

88.0

90.5

0.37

429

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

255

0.84

0.45

2.2

2.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

166

1.21

0.45

1.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

497

3077

0.96

0.44

1.4

1.6

25.2

34.6

iu/ml

1.58

148

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

359

1.14

0.44

1.1

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

282

1.15

0.43

1.3

6.5

5.9

mmol/l

0.26

138

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.43

0.0

1.4

—

(3004768) Phthalic anhydride IgE Ab [Units/volume] in Serum

0.00

0.43

0.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

211

1.18

0.42

1.1

—

(3010503) CD19 cells [#/volume] in Blood

300

1677

1.06

0.42

2.3

2.7

0.2

0.3

e9/l

0.23

287

1640

(3011288) Drugs identified in Urine by Screen method

1104

6349

1.03

0.42

4.1

3.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

447

0.89

0.40

1.3

1.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

112

604

1.10

0.40

1.1

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

493

2796

1.04

0.40

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

273

1.15

0.40

1.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

224

1.16

0.39

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

133

725

1.09

0.39

1.5

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

519

0.90

0.38

1.2

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

772

4426

1.03

0.37

1.2

2.6

3.8

u/ml

1.75

234

1511

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

192

1.17

0.37

1.2

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

1.30

0.37

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

255

1427

1.06

0.37

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

203

1128

1.07

0.37

2.2

2.4

55.6

53.3

umol/l

0.45

164

932

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.48

0.37

1.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

369

2087

1.05

0.36

1.6

1.9

4.4

3.4

mg/l

4.15

347

2000

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.42

0.36

2.0

1.7

—

(3022670) pH of Venous cord blood

1.42

0.36

1.3

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

269

1678

0.95

0.36

1.1

—

(3016879) Cocaine [Presence] in Urine

1489

9005

0.98

0.36

2.5

2.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

155

1.18

0.35

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

546

0.91

0.34

1.2

—

(40758358) Immune stain study

132

0.81

0.34

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

425

2617

0.96

0.34

4.5

4.9

37.2

118.6

u/ml

4.99

109

817

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

259

0.87

0.33

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

234

1312

1.06

0.33

1.2

1.1

2.8

11.7

u/ml

1.83

117

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

520

0.91

0.33

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

520

0.91

0.33

1.2

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

267

1.13

0.33

1.0

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

178

990

1.06

0.33

2.0

59.2

54.8

ug/l

0.34

173

965

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

208

0.85

0.33

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

279

1573

1.05

0.32

1.1

u/l

0.02

135

709

(3026470) Cobalt [Mass/volume] in Blood

283

1597

1.05

0.32

2.0

3.5

3.7

ug/l

0.14

242

1425

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.69

0.31

1.6

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

513

2935

1.03

0.31

1.1

30.7

33.3

au/ml

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

353

1.11

0.31

3.2

2.3

0.6

u/field

0.22

353

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.29

0.30

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1277

7716

0.98

0.30

1.1

3.7

5.6

u/ml

1.60

114

1059

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

328

1861

1.04

0.30

2.4

1.7

—

(3041672) Baker's yeast Ab [Presence] in Serum

117

0.81

0.30

1.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

1.26

0.30

2.4

2.7

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.26

0.30

1.7

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

108

688

0.93

0.29

1.2

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

502

1.08

0.29

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

266

1647

0.96

0.29

2.4

2.8

38.7

39.0

0.07

534

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.28

0.28

1.9

2.0

—

(36303858) Crystals [Presence] in Urine

1.28

0.28

1.1

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.28

0.28

1.9

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.28

0.28

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.28

0.28

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.28

0.28

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.28

0.28

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.23

0.27

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

302

1716

1.04

0.27

1.1

ratio

0.09

109

584

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

287

1629

1.04

0.27

1.0

1.1

3.5

5.5

nmol/l

0.59

320

(3011412) CD3 cells [#/volume] in Blood

463

2653

1.03

0.27

2.1

2.5

1.3

1.1

e9/l

1.67

309

1525

(3039162) Centromere protein B Ab [Units/volume] in Serum

619

3564

1.03

0.27

1.2

1.3

47.9

56.5

u/ml

0.31

248

(3036312) Salmon IgE Ab [Units/volume] in Serum

153

0.85

0.26

1.1

1.0

0.0

0.6

u/ml

1.67

111

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

110

1.18

0.26

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

206

1278

0.95

0.26

1.0

1.1

105.9

97.4

3.06

160

1016

(3025577) Chromium [Mass/volume] in Blood

275

1563

1.04

0.25

2.0

2.1

2.4

ug/l

0.54

224

1324

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

215

0.88

0.25

5.2

5.9

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.72

0.25

1.0

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

289

0.90

0.24

2.6

3.0

1.4

1.2

mg/l

0.37

198

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

106

668

0.94

0.23

1.5

1.6

0.4

ug/l

0.38

441

(4027681)

280

1720

0.96

0.23

1.2

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

851

5142

0.98

0.23

1.6

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

156

1.14

0.23

1.3

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.74

0.23

1.6

1.3

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

162

1.13

0.23

1.2

1.0

2.8

2.9

u/l

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

357

2180

0.97

0.22

1.1

300.0

268.3

mg/l

1.65

314

1923

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.22

0.0

2.5

—

4.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

144

0.86

0.22

1.0

1.1

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.22

0.0

1.1

—

1.3

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

424

1.07

0.22

1.2

1.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.82

0.22

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

274

0.91

0.21

1.7

2.1

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

372

2268

0.97

0.21

1.2

47.0

42.3

mg/l

0.91

317

1907

(3049242) von Willebrand panel - Platelet poor plasma

0.83

0.21

1.2

1.8

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

293

1793

0.97

0.21

1.1

7.9

8.6

iu/ml

0.26

479

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

445

2705

0.97

0.21

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.25

0.21

1.4

2.6

2.7

1.7

mu/l

0.31

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

103

646

0.94

0.21

1.0

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.20

0.21

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

141

1.13

0.20

1.4

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

132

821

0.95

0.20

1.6

1.5

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

1.26

0.20

1.1

—

27.7

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

136

1.13

0.19

1.1

—

(3023410) Appearance of Cerebral spinal fluid

461

2796

0.98

0.19

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

539

3119

1.02

0.19

1.2

1.1

99.1

96.2

1.56

508

2909

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

173

0.89

0.19

1.7

1.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

347

1.07

0.19

1.5

1.2

0.2

0.3

nmol/l

0.80

242

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

176

1.11

0.19

1.2

1.4

—

(3040794) Aluminum [Moles/volume] in Urine

1.22

0.18

1.1

1.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

112

630

1.05

0.18

1.2

613.3

503.8

titre

—

(3029075) Extractable nuclear Ab panel - Serum

142

804

1.05

0.18

1.1

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

160

0.89

0.18

2.0

1.3

1.5

1.6

0.02

110

(3007700) Barley IgE Ab [Units/volume] in Serum

122

0.87

0.17

1.1

1.0

0.1

0.5

u/ml

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

180

1105

0.96

0.17

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

287

1747

0.97

0.17

6.1

6.6

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

159

0.89

0.17

1.9

1.6

0.7

umol/l

0.05

121

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

166

1020

0.96

0.17

1.6

2.1

28.3

29.3

0.41

159

958

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

194

1110

1.03

0.16

1.1

481.7

624.2

ng/l

0.24

246

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

218

1251

1.03

0.15

2.7

2.2

20.4

242.2

ug/l

1.83

210

1192

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

201

0.91

0.15

1.0

1.5

0.4

u/ml

0.35

114

(4268621)

507

2944

1.02

0.15

2.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

105

1.13

0.15

1.7

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1235

7225

1.01

0.15

1.2

1.3

6.0

6.3

u/ml

0.06

795

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

151

0.90

0.14

1.0

0.1

1.4

u/ml

0.85

115

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

214

1.08

0.14

1.4

1.6

2.2

2.7

mg/l

0.23

153

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

214

1.08

0.14

1.4

1.6

2.2

2.1

mg/l

0.01

161

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

214

1.08

0.14

1.4

1.6

0.5

2.4

mg/l

4.49

144

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

214

1.08

0.14

1.4

1.6

0.8

1.0

mg/l

0.19

130

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

214

1.08

0.14

1.4

1.6

3.9

3.7

mg/l

0.07

140

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

214

1.08

0.14

1.4

1.6

1.0

mg/l

0.03

138

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

214

1.08

0.14

1.4

1.6

1.9

mg/l

0.17

150

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

214

1.08

0.14

1.4

1.6

1.4

1.9

mg/l

0.37

126

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

214

1.08

0.14

1.4

1.6

2.4

2.3

mg/l

0.05

144

(3006245) CD3-CD19+ cells/100 cells in Blood

168

1026

0.97

0.13

1.6

2.2

11.6

9.6

1.11

156

947

(3034426) Prothrombin time (PT)

170

976

1.03

0.13

1.3

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2404

14130

1.01

0.12

1.1

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

186

0.92

0.12

2.0

1.5

16.4

12.6

0.31

138

(3016031) Almond IgE Ab [Units/volume] in Serum

143

0.91

0.12

1.0

0.2

0.3

u/ml

0.23

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

532

3195

0.99

0.11

1.8

1.9

3131.4

3643.8

titre

0.13

157

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

173

1052

0.97

0.11

2.7

3.0

26.8

28.8

umol/l

1.37

119

823

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2535

15095

0.99

0.11

3.0

3.4

58.4

49.7

u/ml

0.85

2425

14594

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1251

7338

1.01

0.11

1.2

1.3

4.3

8.0

u/ml

3.56

150

1219

(3019174) dRVVT (LA screen)

257

1.06

0.11

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

168

1021

0.97

0.11

1.6

1.7

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.88

0.10

1.2

1.0

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

102

1.10

0.10

1.5

2.6

36.2

14.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

125

1.09

0.10

1.7

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

281

1.05

0.10

1.1

1.0

—

(3013762) Body weight Measured

111

0.91

0.10

1.0

1.1

—

(3006840) Garlic IgE Ab [Units/volume] in Serum

1.10

0.10

1.0

0.1

0.2

u/ml

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.10

0.10

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.87

0.10

1.0

—

(4306422)

741

4340

1.01

0.09

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

232

0.94

0.09

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

253

1.05

0.09

1.0

6.0

4.3

u/ml

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.11

0.09

1.8

2.3

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.04

0.08

1.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

219

1.05

0.08

1.4

1.6

0.6

1.9

mg/l

3.27

141

(3003157) Bacteria [#/volume] in Mother's milk

0.83

0.08

3.5

7.9

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.86

0.07

1.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

197

1.05

0.07

1.0

1.1

—

(3007733) Chloride [Moles/volume] in Urine

0.86

0.07

1.0

1.1

96.5

79.8

mmol/l

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.86

0.07

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.86

0.07

1.0

1.3

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

127

0.93

0.07

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

320

1.04

0.06

1.3

—

(3050794) Legionella sp Ab [Presence] in Serum

250

1.04

0.06

1.1

1.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

217

0.95

0.06

1.0

0.4

0.1

u/ml

0.42

123

(40768795) Lymph node Pathology biopsy report

467

2790

0.99

0.06

1.2

—

(40762814) Titanium [Mass/volume] in Blood

455

1.03

0.06

2.3

3.0

4.0

ug/l

2.00

164

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

379

1.03

0.06

1.2

1.1

0.3

0.4

u/ml

0.22

237

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

727

4333

0.99

0.06

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

204

1.04

0.05

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

444

2605

1.01

0.05

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1122

6610

1.00

0.05

1.4

176.8

123.6

pmol/l

1.68

1085

6463

(44806071)

375

1.03

0.04

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

500

2939

1.01

0.04

1.6

2.0

9.7

7.0

umol/l

1.06

373

2121

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

227

0.96

0.04

1.1

—

(3003577) Lead [Moles/volume] in Blood

221

0.96

0.04

1.5

1.4

0.2

umol/l

1.05

(3007542) Rye IgE Ab [Units/volume] in Serum

137

0.95

0.04

1.1

1.0

0.9

0.3

u/ml

0.41

(3044009) aPTT.lupus sensitive (LA screen)

262

0.97

0.03

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

131

785

0.99

0.03

1.0

1.1

12.4

9.3

u/ml

0.31

113

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.08

0.03

1.2

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1349

7965

1.00

0.02

1.2

1.3

36.9

u/ml

0.00

528

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

710

4189

1.00

0.02

1.1

122.5

118.0

2.77

643

3778

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

117

0.96

0.01

1.3

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1589

9391

1.00

0.01

1.6

1.7

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

415

1.01

0.01

1.2

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

1.05

0.01

1.3

1.2

7.6

19.0

mmol/l

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.94

0.01

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

156

1.02

0.00

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

186

0.99

0.00

1.1

1.0

0.5

0.2

u/ml

0.46

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

209

0.99

0.00

1.9

1.5

34.2

39.1

0.27

143

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

209

0.99

0.00

1.0

0.0

u/ml

0.17

115

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

186

1.02

0.00

1.1

15.7

14.5

nmol/l

—

(3007463) Buprenorphine [Presence] in Urine

103

0.98

0.00

5.9

8.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

165

1.00

0.00

1.1

—

(3024316) Viscosity of Plasma

140

1.01

0.00

1.6

1.8

1.5

1.8

mpas

1.97

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.00

0.00

1.0

1.1

2.2

2.6

—

(3045191) Normetanephrine [Moles/volume] in Urine

0.00

0.0

1.2

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.6

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.91

0.00

1.2

1.1

1591.7

2089.5

titre

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.90

0.00

2.2

2.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.89

0.00

1.2

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: T2D_INCLAVO – Type 2 diabetes, definitions combined, including avohilmo

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Type 2 diabetes, definitions combined, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Type 2 diabetes, definitions combined, including avohilmo (T2D_INCLAVO)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints